Magical VC Setting FiO2 100-PEEP 5-RR 15-TV 400: In Volume Control (VC) mode, initial settings such as FiO2 at 100%, PEEP at 5 cm H2O, a respiratory rate of 15 breaths per minute, and a tidal volume of 400 mL provide a foundational approach for the management of mechanically ventilated patients. These parameters serve as starting points and must be finely adjusted based on the patient's specific needs and responses, with ongoing monitoring to ensure optimal outcomes.
MV without Referring to PBW: While minute ventilation (MV) calculations ideally utilize predicted body weight (PBW) for accuracy, emergency clinical scenarios might necessitate quick estimations without immediate access to detailed PBW tables. Under such circumstances, a rough MV can be quickly calculated based on the patient's weight: approximately 5 liters per minute for a 50 kg patient, 6 liters for a 60 kg patient, and 7 liters for a 70 kg patient. These preliminary estimates are vital for initial ventilator setup, requiring subsequent adjustments as more information becomes available or as the patient's condition evolves.
Lung Condition Without Cdyn but Quickly Using Plateau Pressure: Dynamic compliance (Cdyn), a detailed measure of lung condition, typically considers values greater than 50 mL/cm H2O as normal, while lower values suggest potential ARDS, necessitating further diagnostics like chest X-rays. However, measuring Cdyn involves time-consuming inspiratory and expiratory holds. A quicker clinical alternative is to observe the plateau pressure. If the plateau pressure, based on an accurate MV computation per PBW, remains below 30 cm H2O, it suggests that the lungs are likely not severely compromised, indicating that the current ventilatory support is within safe limits and avoiding undue lung stress. If the difference between the peak pressure and plateau pressure is less than 5 cm H2O, it may indicate that the lung condition is within an acceptable range.
PEEP Setting Adjustments Based on Chest X-ray Findings: A clear chest X-ray typically warrants a PEEP of 5 cm H2O, while mild, moderate, and severe infiltrations might necessitate settings of 10, 15, and 20 cm H2O, respectively. However, maintaining PEEP below 12 cm H2O is generally advisable to avoid decreasing cardiac output and blood pressure:
FiO2 | 100 | 90 | 80 | 70 | 60 | 50 | 40 | 30 |
---|---|---|---|---|---|---|---|---|
PEEP | 12 | 11 | 10 | 9 | 8 | 7 | 6 | 5 |
Monitoring with Trend Feature - Airway Resistance Associated with Peak Pressure and Lung Condition with Plateau Pressure: When airway resistance increases, it is typically observed as a rise in peak pressure in the ventilator, while plateau pressure remains stable, particularly noticeable in Volume Control (VC) mode. Absence of an upper limit for peak pressure can cause significant increases. Conditions like pneumonia can escalate both peak and plateau pressures, necessitating rigorous monitoring. Utilizing the "Trend" feature of ventilators is crucial as it helps monitor these pressures over 24 hours, facilitating informed clinical decisions. If peak pressure rises while plateau pressure remains stable, this suggests increased airway resistance. Conversely, an increase in both peak and plateau pressures, or just plateau pressure, can indicate deteriorating lung compliance, potentially requiring further assessments such as a chest X-ray.
Use of Ventilator Loop Features: In ventilator management, the loop feature is an invaluable tool for comparing the current respiratory status against specific points in the past, helping identify changes and trends in a patient's condition. Modern ventilators, such as Servo ventilators, often feature a button labeled "Freeze," "Reference," or "Hold" that allows clinicians to compare the current loop with those from previous time points. By pressing this button, you can capture the current graph and overlay it with a graph from a previous time, facilitating a visual comparison of respiratory mechanics. This is particularly useful for evaluating changes when symptoms like sputum obstruction are present.
The Lower Inflection Point (LIP) on the pressure-volume loop provides crucial insights into the patient's respiratory mechanics. If the LIP shifts slightly to the right, it often correlates with airway obstruction, such as the presence of sputum, indicating that higher pressure is needed to overcome the resistance and begin inflating the lungs. Conversely, if the LIP remains the same or appears swollen (wider), it may suggest intrinsic lung issues, such as reduced lung compliance seen in conditions like ARDS or fibrosis, where the lung tissue is stiffer and harder to inflate. Increased airway resistance typically causes a rightward shift of the LIP without necessarily causing it to swell. Understanding these differences helps clinicians make informed decisions about ventilator management and patient care.Note: It is crucial to customize all ventilator settings to the individual needs of the patient, considering their specific medical conditions, responsiveness to initial settings, and changes in their clinical status. This guide provides a foundational framework and should be utilized in conjunction with the latest clinical guidelines and under the supervision of experienced clinicians.
Effective lung protection strategies are essential in mechanical ventilation, particularly when managing conditions such as Acute Respiratory Distress Syndrome (ARDS) and Chronic Obstructive Pulmonary Disease (COPD).
Plateau Pressure Management: It is crucial to keep the peak inspiratory pressure (PIP) below 40 cm H2O to mitigate the risk of barotrauma and volutrauma. For ARDS patients, ensuring the plateau pressure remains at or below 30 cm H2O is imperative. The driving pressure — defined as the difference between plateau pressure and Positive End-Expiratory Pressure (PEEP), also known as 'Pressure above PEEP' — should not exceed 15 cm H2O to prevent lung injury. This approach, supported by findings from Marcelo B.P. Amato et al. (NEJM, 2015), demonstrates that maintaining the driving pressure below 15 cm H2O significantly enhances survival outcomes by minimizing lung stress and reducing the risk of ventilator-induced lung injury (VILI).
Considerations for Managing Airflow Obstruction in COPD and Complicated Cases: In conditions like COPD where severe airflow obstruction is prevalent, it may be necessary to maintain a peak inspiratory pressure above 50 cm H2O to ensure adequate ventilation, especially since the plateau pressure is likely to stay below 30 cm H2O. This helps prevent hypoventilation and maintains sufficient oxygen delivery. However, special caution is necessary when COPD is complicated by conditions like new onset pneumonia, where unrestricted peak pressures can significantly increase plateau pressures, elevating the risk of lung injury. It is essential to meticulously monitor and adjust ventilator settings to keep the plateau pressure within safe limits.
Tidal Volume Adjustment: To prevent lung overdistension and minimize the risk of VILI, a lower tidal volume of 4 to 6 mL/kg of predicted body weight (PBW) is recommended for ARDS patients. Patients without ARDS can typically tolerate a standard tidal volume ranging from 6 to 8 mL/kg of PBW. (Generally, a lung condition is considered stable if the plateau pressure remains below 30 cm H2O, even when a tidal volume of 400 mL is used. This stability indicates that the lungs are not being overdistended and that the mechanical ventilation is within safe limits to support the patient's respiratory needs without causing additional harm.)
This calculator estimates essential ventilator parameters in either Volume Control (VC) or Pressure Control (PC) mode using the following steps:
We then round the result to one decimal place. PBW is used because actual body weight can overestimate lung size in obesity or fluid overload scenarios. Using PBW helps avoid excessive tidal volumes.
Once we have a target VT, the calculator solves for respiratory rate: \[ \text{RR} = \frac{\text{MV}}{\text{VT}_{\text{in liters}}} \]
Vt |
PEEP | Resp. rate |
Ti (NL: 0.8–1.2 s) |
Flow Shape | |||
Safety Vt |
Trigger |
P control |
PEEP | Resp. rate |
Ti (NL: 0.8–1.2 s) |
Rise time |
|||
Safety Vt |
Trigger |
Volume Control (VC)
VC Ventilator Settings
|
Pressure Control (PC)
PC Ventilator Settings
|
The table below provides a structured overview of common ventilator modes, arranged from those relying primarily on machine-driven parameters to those granting greater patient autonomy. Each mode lists the primary control variable, mandatory settings (with typical ranges where applicable), and additional adjustable parameters. The ranges and values are considered guidelines and may vary depending on clinical judgment and individual patient needs.
Mode | Primary Control Variable | Mandatory Settings | Additional Settings |
---|---|---|---|
VC (Volume Control) | Volume |
|
|
PC (Pressure Control) | Pressure |
|
|
PRVC (Pressure Regulated Volume Control) | Volume-targeted, Pressure-limited |
|
|
SIMV VC + PS | Volume (Mandatory) & Pressure (Spont.) |
|
|
SIMV PC + PS | Pressure (Mandatory) & Pressure (Spont.) |
|
|
PS (Pressure Support) | Pressure (Spontaneous) |
|
|
% Pressure Support is for intubated or non-intubated patients, depending on their needs. |
|||
ST (Spontaneous/Timed, NIV) | Pressure (with backup) |
|
|
BiPAP (NIV) | Pressure (Spontaneous) |
|
|
CPAP | Pressure (Spontaneous) |
|
|
SV (Spontaneous Ventilation) | Patient-driven |
|
|
ST & SV Integrated | Pressure (with backup) |
|
|
Ventilator modes such as ST (Spontaneous/Timed, Non-Invasive Ventilation) and SV (Spontaneous Ventilation) provide respiratory support tailored to various clinical needs. These modes range from offering a combination of spontaneous and timed breaths to facilitating entirely patient-driven breathing efforts. Modern ventilators often integrate ST and SV modes to enhance flexibility and adaptability in managing patient care, particularly in non-invasive applications.
ST mode, also known as Spontaneous/Timed Non-Invasive Ventilation (NIV), delivers patient-initiated spontaneous breaths combined with ventilator-delivered timed breaths. It is intended for patients capable of breathing spontaneously but who require additional support to maintain adequate ventilation and oxygenation.
SV mode relies entirely on the patient’s own respiratory drive, providing minimal or no machine assistance. It is suitable for patients who are largely breathing independently but may benefit from occasional support to reduce the work of breathing.
Modern ventilators that integrate ST and SV modes offer notable advantages, ensuring that respiratory support is appropriately matched to changing patient conditions.
Enhanced Flexibility: Integrating ST and SV allows tailoring of respiratory support to the patient’s evolving status. For example, a patient may benefit from more controlled assistance at one point and require greater freedom for spontaneous breathing at another. This dynamic adjustment helps maintain optimal ventilation with minimal manual intervention.
Optimized Patient Comfort and Compliance: By providing both timed mandatory breaths and opportunities for spontaneous ventilation, integrated modes align with natural breathing patterns, often improving patient comfort and reducing the perception of reliance on a machine. Enhanced synchrony between the patient and ventilator may also decrease sedation requirements and facilitate a more rapid recovery.
Improved Clinical Outcomes: Integrated ST and SV modes support gradual weaning from mechanical ventilation by offering appropriate assistance as respiratory function improves. They can adapt to changes in a patient’s respiratory mechanics, ensuring consistent and adequate support without excessive intervention.
Comprehensive Support for Various Clinical Scenarios: These integrated modes are beneficial in a wide range of clinical situations, from acute respiratory distress to chronic respiratory conditions. The ability to deliver ST and SV non-invasively expands their applicability to patients who may not tolerate invasive ventilation, improving overall patient management strategies.
Written on December 12th, 2024
SIMV-PCV-PS is a ventilator mode that integrates Synchronized Intermittent Mandatory Ventilation (SIMV), Pressure Control Ventilation (PCV), and Pressure Support (PS). This configuration ensures that the ventilator delivers a set number of mandatory breaths at a predetermined pressure as defined by PCV. These breaths are synchronized with any spontaneous efforts by the patient, maintaining necessary ventilation support even in the absence of patient-initiated breathing.
In this mode, if the patient initiates a spontaneous breath, the ventilator shifts to Pressure Support (PS) mode. PS applies a consistent pressure during these spontaneous breaths, facilitating easier breathing by reducing the effort needed to inhale. If no spontaneous efforts occur, the ventilator continues with mandatory PCV breaths, providing uninterrupted support. Therefore, PS is only active during patient-initiated breathing; otherwise, ventilation defaults to the controlled settings of PCV.
Practically speaking, a significant advantage of Volume Control (VC) ventilation is its ability to allow a single clinician to manage multiple patients simultaneously, especially in scenarios that require interventions like sputum suction, which can decrease minute ventilation (MV). In such situations, VC automatically increases the peak pressure to maintain the predetermined tidal volume (TV), giving clinicians additional flexibility and time to manage other tasks. Conversely, Pressure Control (PC) ventilation maintains a fixed pressure, which does not automatically adjust in response to changes in patient conditions, such as diminished TV due to airway obstruction. This characteristic necessitates a more immediate and direct response from clinical staff to ensure patient safety and effective ventilation.
Pressure Control (PC) ventilation offers several significant benefits due to its decelerating flow characteristics. Firstly, it is highly recommended for neonates because it reduces the risk of complications. Secondly, PC ventilation typically results in lower peak inspiratory pressures (PIP), which can minimize the risk of lung injury. The decelerating flow pattern in PC ventilation results in lower PIP because it better accommodates the natural compliance and resistance of the lungs. In contrast, the constant flow pattern in Volume Control (VC) ventilation can lead to higher PIP due to the inability to adjust to varying airway resistance dynamically. Additionally, an increase in mean airway pressure (MAP) can reduce dead space and enhance oxygenation. Furthermore, PC improves patient-ventilator synchrony and reduces the work of breathing (WOB), thereby decreasing the likelihood of the patient 'fighting' the ventilator. This is particularly advantageous as PC allows for flexible adjustment of the inspiration time, contributing to more natural breathing patterns that better meet the dynamic needs of the patient.
Plateau Pressure: In Volume Control (VC) mode, plateau pressure is not directly visible during regular ventilation cycles. It must be measured using an inspiratory pause, where airflow is briefly halted at the end of inspiration to allow pressures within the lung to equalize, giving a true measure of plateau pressure. Also, during the T-pause, which is the pause time during VC mode, the plateau pressure is estimated effectively due to the cessation of airflow, which allows for pressure equilibration across the pulmonary system, reflecting the pressure exerted by the ventilator against the lung compliance. In Pressure Control (PC) mode, since the ventilator delivers a preset pressure and maintains it throughout the inspiratory phase, the peak pressure is effectively the plateau pressure.
Pressure Regulated Volume Control (PRVC) integrates the precision of Volume Control (VC) with the protective features of Pressure Control (PC), forming a unique and dynamic approach to mechanical ventilation. In this mode, a preset tidal volume is targeted, much like in VC, but the delivery method adapts characteristics of PC by adjusting the inspiratory pressure automatically on a breath-to-breath basis. This adaptability ensures the set volume is delivered with the minimum necessary pressure, enhancing patient safety by reducing the risk of barotrauma. The key settings include not only the tidal volume but also an adjustable inspiratory pressure (capped at an upper limit to prevent lung injury), respiratory rate, inspiratory time, and positive end-expiratory pressure (PEEP), which aids in maintaining alveolar stability and improving oxygenation.
The operational flexibility of PRVC becomes particularly advantageous when managing patients with variable lung mechanics. If a drop in the delivered tidal volume is detected, the system initially applies a volume-type strategy, automatically adjusting to a pressure-type mode if the volume shortfall persists. This ensures the intended tidal volume is maintained even under changing physiological conditions. As the patient's lung mechanics stabilize and tidal volume recovers, the system responsively lowers the peak pressure. This dynamic adjustment not only optimizes gas exchange and lung protection but also minimizes the risk of ventilator-induced lung injuries, making PRVC an essential tool in modern respiratory care, particularly in scenarios where both volume consistency and pressure mitigation are critical. (Additionally, PRVC employs a decelerating flow waveform, similar to PC, enhancing gas exchange and matching ventilation closely to the patient's needs.)
Drawbacks: If the patient's airway resistance increases, the peak pressure cannot rise as rapidly or effectively as in PC mode due to the inherent limitations of PRVC. PRVC adjusts pressure gradually, both increasing and decreasing it slowly. This slower adjustment can lead to delays in reaching the necessary inspiratory pressure during sudden changes in the patient's airway resistance or compliance, making PRVC less responsive in acute situations where rapid pressure adjustments are necessary. Additionally, PRVC's dependence on accurate real-time respiratory data means that sudden changes in the patient's condition or data errors might prevent timely adjustments, potentially leading to inappropriate ventilatory support. Noteworthily, during procedures such as sputum suctioning, the removal of airway obstructions can suddenly reduce airway resistance. PRVC might respond by delivering a higher tidal volume than intended before recalibrating, risking overdistension of the lungs. This potential for increased tidal volume underscores the importance of careful monitoring during such procedures.
Ventilator pressure modes are categorized into controlled and support modes, each tailored to different patient needs. In controlled mode, the ventilator autonomously delivers breaths at preset times and volumes, which is essential for patients who are unconscious or unable to breathe voluntarily. This mode ensures that the patient receives adequate ventilation without relying on their respiratory effort, leading to generally seamless synchrony between the patient and the ventilator due to the absence of patient-initiated breathing efforts.
Conversely, support mode is designed to work in harmony with the patient's own respiratory efforts. It dynamically adjusts variables such as the inspiratory to expiratory (I:E) ratio, inspiratory time, tidal volume, and trigger sensitivity based on the patient's initiated breaths. This mode is particularly beneficial for conscious patients who are capable of voluntary breathing but still require assistance to maintain adequate ventilation. However, achieving synchrony in support mode can be challenging, as the ventilator must finely tune its responses to closely match the timing and intensity of the patient's spontaneous breaths.
Specific considerations arise within these modes, especially concerning Pressure Control (PC) and Pressure Support (PS) ventilation. In PC mode, patients with conscious and voluntary breathing may face synchrony challenges because the fixed pressure delivery might not align perfectly with their natural breathing patterns. This misalignment can lead to discomfort or inefficiency in ventilation support.
In contrast, PS mode often proves more suitable for conscious patients who can initiate breaths. This mode allows for a more natural interaction with the ventilator, which can significantly improve both synchrony and comfort by adapting the ventilation support more closely to the patient's actual respiratory needs. The inspiratory time in PS mode isn't set by the clinician but is instead determined by the patient's inspiratory effort and the cycle-off criteria, typically based on a percentage of peak inspiratory flow. This approach makes the inspiration time more dynamic and patient-driven, reflecting their current respiratory status and contributing to a more personalized ventilation strategy.
Overall, support mode is crucial for patients who are capable of participating in their own breathing yet require assistance to achieve or maintain adequate ventilation. This mode's flexibility helps accommodate individual respiratory patterns and reduces the work of breathing, making it a preferred option for patients in the process of recovering respiratory function.
Adjusting inspiratory settings for better outcomes in mechanical ventilation involves meticulous management of the dynamics between Pressure Control (PC) and Pressure Support (PS) ventilation modes. In PC ventilation, manual adjustment of the inspiratory time (Ti) is crucial to maintain patient-ventilator synchrony. Typically, longer Ti settings are well-tolerated during sleep, but adjustments may be necessary when a patient awakens and becomes more active. Changes in the breathing pattern, often observable on the pressure graph as an upward trend at the end of inspiration, indicate the patient's attempt to exhale while the ventilator continues to deliver air. Reducing Ti in these instances helps align the ventilator support with the patient's natural desire to breathe more shallowly or exhale, thereby reducing the risk of patient-ventilator asynchrony, often referred to as "fighting the ventilator."
In PS ventilation, the inspiratory cycle-off setting is critical. This setting determines when the ventilator ceases inspiratory pressure support and transitions to expiration, based on a predefined percentage of peak inspiratory flow. Typically, the inspiratory cycle-off is set to terminate inspiration at about 25% of the peak inspiratory flow. Adjustments to this setting are necessary when patients exhibit signs of discomfort or asynchrony, such as trying to exhale while still in the inspiratory phase. Decreasing this percentage to around 15% can allow the ventilator to switch to the expiratory phase sooner, thus reducing the risk of breath stacking and enhancing comfort. This adjustment better synchronizes the ventilator with the patient's breathing efforts, particularly if the patient completes their inhalation quickly or feels that the breaths are too long. Conversely, increasing the cycle-off percentage to around 50% prolongs the time the ventilator provides support during inhalation. This can be beneficial if the patient feels they are not getting enough air before the ventilator cycles off, as it allows more complete inhalation according to the patient's needs.
However, in PS mode, adjusting Ti is not an option since it is inherently designed to be patient-driven. The duration of inspiration is determined by the patient's inspiratory effort and the cycle-off setting, rather than a fixed time set by the clinician. This design emphasizes the supportive nature of PS ventilation, giving patients greater control over their breathing patterns, which is especially vital for those with varying levels of respiratory drive. This approach allows inspiration time to be more dynamic and patient-driven, reflecting their current respiratory needs and efforts, and enhances overall patient comfort and ventilator efficiency.
Double triggering is a significant issue in mechanical ventilation, particularly in Pressure Support (PS) and Pressure Control (PC) modes, with a higher occurrence in PS. This phenomenon arises when the ventilator's sensitivity settings fail to align with the patient's actual respiratory demands, or if the inspiratory time set by the device does not synchronize with the patient's natural breathing pattern. Such misalignments can lead to a scenario where a patient initiates a second breath while the first is still being completed, potentially disrupting both patient comfort and the efficiency of the ventilation process.
In PS mode, the ventilator responds to the patient's breathing efforts, and if these efforts trigger the ventilator prematurely during the inspiratory cycle, double triggering may occur. This typically happens if the patient attempts to breathe in again before the machine has completed the cycle, which ideally should transition into expiration. In PC mode, although the ventilators are programmed with preset inspiratory times to mitigate this issue by strictly controlling the breathing cycles, mismatches with the patient's natural respiratory rhythm can still lead to synchronization problems and subsequent double triggering.
To manage and prevent double triggering effectively, it is crucial to ensure that the ventilator settings are meticulously adjusted to the patient's current respiratory status. This includes fine-tuning the sensitivity settings and inspiratory times to better match the patient's natural breathing patterns, thus minimizing the risk of premature initiation of a second breath.
Effective management of ventilator settings, particularly trigger sensitivity, is essential, especially in the presence of leaks. The default setting for flow trigger sensitivity is typically +2, which detects changes in flow rate to initiate ventilation in response to patient-initiated respiratory efforts. To minimize the risk of auto-triggering due to a leak, it may be necessary to adjust this setting to -2 or lower. Settings in negative values use pressure triggers, which are more precise in detecting actual decreases in pressure, thus ensuring a more accurate response to genuine respiratory efforts and reducing false triggers.
For neonatal patients, who exhibit unique respiratory dynamics, a higher sensitivity setting of +5 may be required. This adjustment ensures that the ventilator can effectively detect the subtle respiratory efforts typical in neonates, which might not activate standard sensitivity settings.
In scenarios involving patients with Acute Respiratory Distress Syndrome (ARDS), the severely compromised lung function results in rapid exhalation phases, making Pressure Support Ventilation (PSV) unsuitable. PSV depends heavily on the patient's spontaneous breathing, which may be insufficient or unstable in ARDS cases. Consequently, Pressure Control Ventilation (PCV) is generally preferred as it provides better control over the breathing cycle with fixed pressure delivery, aiding in synchronizing ventilation with the patient's respiratory needs.
However, even in PCV, mismatches between the set inspiratory times and the patient's natural breathing rhythm can lead to double triggering — where the ventilator delivers two breaths in rapid succession without allowing for a full exhalation in between. Managing these cases may necessitate clinicians to adjust the trigger sensitivity to make the ventilator less responsive to minor respiratory efforts, increase the volume settings for more complete breaths, or use sedation to moderate the patient's spontaneous breathing efforts, thereby enhancing overall control over ventilation.
In Pressure Control (PC) mode, rapid increases in pressure at the onset of inspiration can sometimes lead to disruptions in the ventilator's pressure graph, which may appear as abrupt changes or instabilities. Such occurrences can compromise the smooth delivery of ventilation and potentially affect patient comfort. To address this issue, it's essential to adjust the 'T insp rise' setting, which controls the rate at which pressure increases during the inspiratory phase.
Typically, if this setting is at zero (or off), the pressure rise is immediate and steep, leading to what might be perceived as an abrupt start to inspiration. Incrementally adjusting this setting by 5% or 10% allows for a more gradual and controlled pressure increase. This modification helps smooth out the initial pressure transition, thereby stabilizing the pressure graph at the beginning of inspiration. Such adjustments not only enhance the mechanical performance of the ventilator but also improve patient-ventilator synchrony and reduce potential stress on the patient's respiratory system.
In Pressure Control (PC) mode, "PC above PEEP" refers to the pressure set above the baseline Positive End-Expiratory Pressure (PEEP) during the inspiratory phase, and this value is equivalent to the driving pressure. According to the study by Marcelo B.P. Amato et al. (NEJM, 2015), driving pressure (ΔP) is a critical factor associated with survival in patients with acute respiratory distress syndrome (ARDS). The study found that lower driving pressures, achieved by adjusting ventilator settings to avoid increases in peak inspiratory pressure (PIP) while optimizing PEEP, were strongly linked to improved survival rates.
Active Inspiration: Protecting lung integrity is critical, as highlighted by studies such as "Driving Pressure and Survival in the Acute Respiratory Distress Syndrome" by Marcelo B.P. Amato et al. (NEJM, 2015) and "Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress Syndrome" by The Acute Respiratory Distress Syndrome Network (NEJM, 2000). However, strict adherence to these guidelines might lead to insufficient breathing, potentially causing double triggering if patients inhale more than the set tidal volume. To mitigate this, clinicians may consider increasing the tidal volume, adjusting trigger sensitivity, or sedating the patient to decrease spontaneous efforts. Raising the trigger level can enhance ventilator response to patient-initiated breaths, while reducing it helps prevent double triggering. Modifications to ventilator alarm settings, such as the low PEEP alarm, are also often necessary. In Pressure Control (PC) mode, inspiratory time (Ti) is generally set between 0.8 to 1.25 seconds but may be shortened to minimize ventilator conflict. Unlike PC mode, Pressure Support (PS) mode does not allow direct control over Ti, thus incrementally adjusting the "End Inspiration" or "Esens" settings from 30% to 50% can assist in better managing breath termination timing.
Active Expiration: Challenges during expiration, particularly with high Positive End-Expiratory Pressure (PEEP) settings, increase work of breathing (WOB), potentially causing discomfort and leading to non-compliance with ventilation. Shortening the expiratory time in PC mode can effectively address these issues. In PC mode, adjusting the expiratory time primarily involves altering the inspiratory time (Ti) and the respiratory rate (RR), as these settings will indirectly affect how long the expiratory phase lasts. For example, decreasing the Ti from 1.2 seconds to 0.8 seconds and maintaining a consistent respiratory rate will naturally extend the expiratory phase. In Pressure Support (PS) mode, expiratory time adjustment differs since inspiratory time is typically patient-driven. Adjusting the "cycling off" criteria, for instance, setting it to terminate inspiration when the flow decreases to 25% of the peak flow rate, will typically shorten the inspiratory phase and potentially increase the expiratory time.
Managing Leaks: Leaks in Volume Control (VC) mode particularly pose challenges, as they can prevent the ventilator from delivering the set tidal volume accurately. This shortfall in delivered volume can destabilize vital signs and may prompt incorrect ventilator adjustments. "End Inspiration" settings may need to be adjusted upwards (e.g., from 30% to 50%), and "Trigger Pressure" should be set to a less sensitive level (ranging from -10 to -20). Regular checks, such as ensuring proper ET tube cuff pressurization and verifying ventilator integrity with a test lung, are essential for identifying equipment-related issues. If leaks persist, increasing minute ventilation (MV) may temporarily resolve issues until more definitive solutions like reintubation or manual bagging are executed.
Biased Flow: Biased flow maintains a continuous stream of air through the mechanical ventilation system, aiding in keeping airways open and detecting spontaneous breathing efforts. Typically set at 2 liters per minute, biased flow comprises a significant part of the total ventilation volume. For example, out of a total of 9 liters, 7 liters are ventilator-delivered, and 2 liters are biased flow. An active inhalation of 1.6 liters (or 80% of the biased flow) by a patient indicates effective inspiration. For smaller or weaker patients, increasing the biased flow (from 2L to 3L or 4L) ensures even minimal efforts are recognized, thus easing their breathing work. However, too high a setting may induce auto-triggering, where minor disturbances are mistakenly interpreted as breathing attempts. Adjusting sensitivity settings can help mitigate auto-triggering, ensuring the ventilator supports only genuine respiratory efforts.
Neurally Adjusted Ventilatory Assist (NAVA) represents a progressive form of mechanical ventilation that optimizes the synchronization between the ventilator and the patient by leveraging the electrical activity of the diaphragm (EAdi). This technology allows the ventilator to respond dynamically to the patient's breathing needs, ensuring that assistance is provided in direct correlation with their respiratory effort. This method not only enhances comfort but also aligns precisely with the patient's natural respiratory drive, crucial for those who can breathe spontaneously but require additional support due to conditions like respiratory failure or challenges in weaning from mechanical support.
The functionality of NAVA hinges on the continuous monitoring of Edi, which acts as the primary trigger for ventilatory assistance. When a patient initiates a breath, the resulting electrical activity of the diaphragm prompts the ventilator to deliver pressure proportionate to this signal, ceasing as the signal diminishes. This responsive system adapts to the patient's breathing needs in real-time, offering a level of support directly correlated to their respiratory muscle effort, thereby mitigating the risks of over- or under-ventilation and enhancing comfort.
The principle of NAVA lies in its ability to detect and utilize the diaphragm's electrical signals as the direct driver for ventilatory assistance. The ventilator adjusts its support based on real-time changes in EAdi, providing a tailored respiratory aid that prevents the common pitfalls of conventional ventilation, such as asynchrony or mismatched timing and intensity of support. This responsiveness to the patient's own respiratory signals makes NAVA particularly advantageous for patients with varying respiratory drive and those susceptible to discomfort with traditional mechanical ventilation methods. However, the efficacy of NAVA can be compromised in patients with conditions that impede the generation or detection of accurate EAdi signals, such as severe diaphragmatic dysfunction, certain neuromuscular disorders, or obstructive esophageal pathologies that prevent proper catheter placement.
NAVA is particularly beneficial in conditions like Acute Respiratory Distress Syndrome (ARDS) in adults and Respiratory Distress Syndrome (RDS) in neonates. It's also indicated in cases of pulmonary hypertension and scenarios requiring detailed assessment of respiratory activity, such as in central hypoventilation syndrome. However, its application is limited by conditions that affect the diaphragm's ability to generate reliable Edi signals, such as neuromuscular disorders, severe diaphragmatic dysfunction, or esophageal anomalies, which might impede the placement or function of the necessary esophageal catheter.
Setting up a NAVA system requires meticulous initial adjustments to ensure optimal patient support. These settings include establishing the NAVA level, which is calculated by the formula NAVA level x (Edi max - Edi min) + PEEP, and determining the trigger sensitivity. The chosen NAVA level, expressed in cmH2OμV, should aim for a target Edi range of 5-20 μV, adjusted based on observed Edi max values to either enhance or reduce ventilatory support.
Clinically, NAVA has shown to significantly improve patient-ventilator synchrony, reducing the risks associated with mechanical ventilation such as ventilator-induced lung injury. By supporting the natural breathing pattern of the patient rather than overriding it, NAVA facilitates a more physiological form of respiratory support, which can lead to better outcomes in the weaning process and overall patient comfort. Its capability to adjust support based on the patient's immediate respiratory muscle output distinguishes it from other assisted modes like Pressure Support Ventilation (PSV), which may not accurately align support with patient effort.
The real-world application of NAVA, especially in complex clinical scenarios, underscores its significant benefits. Studies have documented improved outcomes in diverse patient populations, including adults with acute respiratory conditions and neonates experiencing respiratory distress (Beck et al., 2009; Breatnach et al., 2010). The ability to maintain effective ventilation despite challenges such as air leaks — common in both invasive and non-invasive forms of ventilation — further demonstrates NAVA's robustness (Beck et al., 2009). Its adaptability extends to non-invasive applications, where it can be used with nasal prongs or masks, allowing for a smoother transition from invasive to non-invasive support and potentially reducing the need for higher pressures typically required in conventional ventilation settings (Makker et al., 2020).
When considering the various modes of mechanical ventilation with spontaneous patient breathing — Spontaneous Timed (ST), BiPAP (Bilevel Positive Airway Pressure), BiVent/APRV (Airway Pressure Release Ventilation), Volume Support (VS), Pressure Support (PS), and CPAP (Continuous Positive Airway Pressure) — it's essential to understand both their operational characteristics and the freedom they afford to patients. Each mode requires specific parameters to be set, ensuring optimal ventilation and patient comfort during respiratory support:
In understanding these modes, it's crucial to note that PS mode with 'PS above PEEP' set at zero essentially functions as CPAP, offering continuous positive airway pressure without additional support during inspiration. This equivalence underscores the versatility of PS mode, adapting its function based on settings to meet patient needs. BiPAP, on the other hand, provides variable pressure support during both inhalation and exhalation, offering enhanced ventilation assistance compared to CPAP or PS alone. However, despite its efficacy, BiPAP may feel more restrictive to patients due to its dual-pressure levels. Conversely, CPAP, whether delivered independently or through PS mode, offers continuous support with less complexity, potentially affording patients a greater sense of freedom in their breathing.
When considering freedom to breathe, PS mode stands out as it allows patients to initiate breaths spontaneously and breathe at their own pace. This mode synchronizes with the patient's respiratory effort, providing additional support when needed, while still allowing for variability in breathing rates and patterns. ST mode, while offering partial ventilatory support, imposes fixed intervals for mandatory breaths, which may feel somewhat restrictive compared to the flexibility of PS mode. BiPAP, with its dual-pressure levels, offers tailored support during both inspiration and expiration but may feel more constraining due to its preset parameters. CPAP, whether provided independently or through PS mode, offers continuous positive airway pressure without additional support during inspiration, providing a stable environment for breathing but potentially lacking the adaptability of PS mode.
BiVent/APRV is notable for its innovative ventilation strategy that emphasizes spontaneous breathing across the entire respiratory cycle. This mode operates by maintaining a high baseline airway pressure to optimize oxygenation and alveolar recruitment, while periodically dropping to a lower pressure to allow for CO2 elimination without disrupting the patient's natural breathing attempts. The high pressure phase supports the alveoli continuously, which is critical for patients experiencing severe respiratory distress. In contrast, the brief, controlled lower pressure phase acts like a sigh, aiding in more effective CO2 removal. This mode's ability to allow spontaneous breathing throughout its cycle offers a significant improvement in patient comfort compared to more traditional, restrictive methods.
Volume Support (VS), on the other hand, provides a blend of controlled and supportive ventilation, ideal for patients who are capable of initiating breaths but require assistance in achieving consistent tidal volumes due to varying respiratory muscle strength or lung compliance. Once a patient initiates a breath in VS mode, the ventilator adjusts the pressure dynamically to deliver a predetermined tidal volume. This adaptability ensures adequate ventilation while permitting the patient to control the timing and frequency of breaths, thereby reducing fatigue and promoting a more natural breathing pattern. Unlike modes such as Pressure Support (PS) or BiPAP, VS not only supports the breath initiated by the patient but also guarantees the delivery of a specific volume, adjusting pressure as needed on a breath-by-breath basis to maintain consistent minute ventilation.
Weaning patients from mechanical ventilation is a critical step in their recovery, marking the transition from artificial support back to natural breathing patterns. Typically, humans breathe using negative pressure, where the diaphragm creates a vacuum that draws air into the lungs. In contrast, mechanical ventilation employs positive pressure to push air into the lungs, which can lead to complications such as barotrauma from excessive air pressure and inadequate gas exchange due to low tidal volumes. To mitigate these issues, sedation often facilitates controlled mechanical ventilation with two primary modes: Volume Control (VC), where tidal volume is precisely regulated, and Pressure Control (PC), which adjusts "PC above PEEP" to ensure consistent lung inflation.
As patients stabilize, ventilator settings transition to support modes that allow more spontaneous breathing efforts. Pressure Support (PS) aids each breath initiated by the patient by maintaining "PS above PEEP," while Continuous Positive Airway Pressure (CPAP) maintains a constant pressure to keep the alveoli open, supporting natural lung function but not directly assisting the breathing effort. A notable challenge with support modes like PS is their inability to control the respiratory rate (RR), which can result in apnea if the patient's spontaneous efforts are insufficient.
Transitioning from Controlled Mandatory Ventilation (CMV) to Assisted/Control Mandatory Ventilation (ACMV) is significant, allowing the start of inspiration to be patient-initiated rather than ventilator-initiated, granting more autonomy in the breathing process. For patients requiring intermittent assistance, Synchronized Intermittent Mandatory Ventilation (SIMV) provides mandatory breaths as a backup, set by the SIMV rate, which defines the frequency of controlled breathing. Crucially, if there is an absence of spontaneous patient breathing, the system reverts from ACMV to CMV, ensuring continuous ventilation. However, between controlled breaths, PS can be activated to provide necessary support.
Moreover, transitioning from PS to CPAP involves shifting the control from "PS above PEEP" to a mode where only PEEP is provided, allowing patients under CPAP to utilize negative pressure for breathing. Significantly, if the inspiration strength in PS is set to zero, it effectively transitions the operation to CPAP, emphasizing passive support through maintained PEEP without additional pressure support. This phase is critical as it encourages patients to engage their respiratory muscles more actively, vital for successful weaning.
Assessing Readiness for Ventilator Weaning Using RSBI and P 0.1: To determine if a patient is ready for weaning from mechanical ventilation, two key measures are often evaluated: the Rapid Shallow Breathing Index (RSBI) and the P 0.1 or Occlusion Pressure. The RSBI is calculated by dividing the respiratory rate (RR) by the expiratory tidal volume (VTe) measured in liters. An RSBI value less than 105 breaths per minute per liter is considered indicative of a patient's readiness for weaning. This index, measured during a spontaneous breathing trial, helps assess the patient's workload of breathing, providing a quantitative basis for evaluating their ability to breathe independently.
Additionally, the P 0.1, which is the negative pressure exerted by the patient in the first 100 milliseconds of an occluded airway, is another crucial measure. A P 0.1 value between 1 to 2 cm H2O suggests a lower respiratory drive, which can indicate that the patient may be ready for weaning. This measure provides insight into the patient's respiratory effort and capacity to maintain adequate breathing without ventilatory support. Both the RSBI and P0.1 are essential in providing a comprehensive assessment of a patient's potential to successfully transition off mechanical ventilation.
Predicts the success of weaning from mechanical ventilation. An RSBI ≤ 105 breaths/min/L is considered an indicator of readiness for weaning.
RSBI = f / VT
Successful weaning from mechanical ventilation requires a holistic evaluation of the patient's clinical status. While the Rapid Shallow Breathing Index (RSBI) is a valuable predictor, it should be considered alongside other critical factors to ensure the patient is ready for spontaneous breathing without mechanical support.
An RSBI of 105 or less is widely accepted as an indicator that the patient may be ready for weaning. This threshold suggests that the patient is likely to tolerate spontaneous breathing effectively.
The patient should exhibit stable blood pressure and heart rate without the need for high doses of vasopressors. Hemodynamic stability indicates that the cardiovascular system can support the increased workload associated with independent breathing.
A PaO₂/FiO₂ ratio greater than 150–200 with minimal positive end-expiratory pressure (PEEP ≤ 5 cm H₂O) demonstrates sufficient gas exchange capacity. This level of oxygenation suggests the lungs can function adequately without extensive ventilatory support.
The patient should be awake, alert, and cooperative. Adequate cognitive function ensures that the patient can manage airway protective reflexes and participate in the weaning process.
A strong cough and the ability to clear secretions are essential. The patient should manage secretions without excessive assistance to reduce the risk of aspiration and respiratory complications.
Secretions should be minimal and easily handled without frequent suctioning. Excessive secretions can obstruct airways and impede successful weaning.
Blood gas analyses should indicate stable respiratory function without significant acidosis (PaCO₂ near the normal range). This stability suggests the patient can maintain adequate ventilation independently.
The patient should require low levels of ventilatory support, indicating readiness to breathe without assistance. Parameters such as low PEEP and low inspiratory pressures are favorable signs.
Adequate nutritional status and electrolyte balance support muscle strength and endurance, which are crucial for sustained spontaneous breathing.
The patient should be free from active infections or fever, as these conditions can increase metabolic demands and respiratory workload, potentially hindering the weaning process.
Emotional and psychological factors can impact respiratory function. The patient should be assessed for anxiety or other psychological conditions that might affect weaning success.
A comprehensive assessment involving a multidisciplinary team is essential to evaluate these factors thoroughly. Each patient's unique clinical context should guide the decision-making process, ensuring that weaning is conducted safely and effectively with close monitoring for any signs of distress or failure.
Computed parameters:
The remaining 6 s (4–10 s) constitute a free period for pressure‑supported breaths only.
Elapsed time (s) | Action | Reason |
---|---|---|
1.2 | Synchronized mandatory breath | Effort detected well before the threshold. |
5.0 | Pressure‑support breath | Mandatory breath already given; free‑period assistance only. |
Elapsed time (s) | Action | Reason |
---|---|---|
3.4 | Synchronized mandatory breath | Effort detected at 85 % of window — still inside threshold. |
Elapsed time (s) | Action | Reason |
---|---|---|
3.6 | Time‑triggered mandatory breath | Threshold reached without effort. |
Clinical pearl: At low SIMV rates, the generous free period (6 s) facilitates respiratory‑muscle engagement yet mandates vigilant monitoring for hypoventilation.
Computed parameters:
No residual free period exists; the ventilator begins a new interval immediately after 3 s.
Elapsed time (s) | Action | Reason |
---|---|---|
0.5 | Synchronized mandatory breath | Effort detected early. |
Elapsed time (s) | Action | Reason |
---|---|---|
2.7 | Time‑triggered mandatory breath | Delivered at the threshold; interval ends at 3 s. |
Clinical pearl: High SIMV rates eliminate free periods, making the mode functionally similar to a fully synchronized controlled mode; inspiratory time and flow must be adjusted to avert insufficient tidal volumes.
Written on June 17, 2025
A brief peak at the very start of inspiration indicates inspiratory pressure overshoot. The pattern appears when the set inspiratory flow or rise-time exceeds the capacity of the lung–airway system (low compliance, high resistance, or a very short rise-time).
Effect of inspiratory rise-time on early pressure overshoot and patient comfort.
(0) Tinsp rise 5 % — factory default; balanced patient comfort.
(1) Tinsp rise 0 % — instantaneous rise; marked early-pressure overshoot (“fighting”).
(2) Tinsp rise 10 % — slower ramp; overshoot minimized, mean airway pressure (Pmean) and delivered tidal volume (VT) fall slightly while synchrony improves.
Inspiratory rise time is the interval from the onset of inspiration to the moment peak inspiratory pressure is reached (some ventilators use a flow-based definition). It is set as a fraction of the total respiratory cycle; with respiratory rate RR = 15 breaths·min–1 (Tcycle = 4 s): \[ T_{\text{rise}} \;=\; f_{\text{rise}}\times T_{\text{cycle}} \;=\; f_{\text{rise}}\times \frac{60}{RR}. \] Thus a 10 % setting yields \(T_{\text{rise}} = 0.10 \times 4\text{ s} = 0.4\text{ s}\). Lengthening Tinsp rise reduces overshoot and dyssynchrony at the cost of a modest drop in VT and Pmean.
A sudden transient rise after inspiration begins most commonly signifies a cough, hiccup, or transient glottic closure. Pressure climbs momentarily because the airway is briefly obstructed.
Upward inflection just before inspiratory flow should cease identifies a premature expiratory effort — an example of expiratory (cycling) asynchrony or “early cycling / flow-termination mismatch.”
A dip below the pressure baseline during inspiration represents a patient inspiratory effort stronger than delivered flow. The airway pressure falls because flow or tidal volume is inadequate.
If spontaneous effort persists after the ventilator cycles off, a second mandatory breath may be triggered, producing two consecutive breaths. This phenomenon denotes double triggering (also called breath stacking).
When measured PEEP drifts below the set PEEP and the expiratory pressure slope falls slowly toward zero, the usual cause is an air-leak (circuit, cuff, or chest drain).
A noticeable fall below PEEP immediately before the inspiratory valve opens reveals a vigorous negative-pressure trigger effort. When excessive, the event is termed excessive negative-pressure trigger and may cause patient discomfort.
The informal phrase “fighting the ventilator” broadly includes any patient–ventilator asynchrony that induces distress, ineffective ventilation, or abnormal work of breathing.
Accurate classification remains crucial: ventilator settings (flow, rise-time, cycling criterion) must be optimised, leaks eliminated, and reflex causes treated before every anomaly is labelled as “fighting.”
Pattern No. | Main cause | Category |
---|---|---|
1 | Rise-time too short / high flow | Machine artifact or Fighting |
2 | Cough / glottic reflex | Physiologic reflex |
3 | Premature expiratory effort | Fighting |
4 | Flow starvation | Fighting |
5 | Double triggering | Fighting |
6 | Air-leak | Circuit fault |
7 | Excessive negative trigger | Fighting |
- Inspect the circuit for leaks, condensate, and cuff pressure.
- Match inspiratory flow to demand; increase peak flow or prolong rise-time if negative scoops occur.
- Adjust cycling criteria in pressure-support modes (e.g., raise the %-peak-flow threshold) to prevent premature expiratory effort.
- Evaluate sedation and analgesia if coughs, double triggering, or vigorous efforts continue.
- Consider proportional-assist or NAVA when conventional modes cannot achieve synchrony.
Written on June 7, 2025
In a normal passive breath, expiratory flow decays exponentially to baseline within ≈1 s. Obstructive diseases (COPD, asthma) lengthen the time constant, producing a gently sloping tail that fails to reach zero before the next inspiration.
When inspiratory flow begins while expiratory flow is still positive, residual gas remains in the lungs.
A brief reversal of flow halfway through exhalation reflects a premature spontaneous inspiratory effort that prematurely retriggers the ventilator.
A long stretch of nearly constant, low expiratory flow followed by an abrupt drop suggests dynamic airway collapse or a pursed-lip–breathing effect.
Fine, regular undulations superimposed on the descending limb usually stem from secretions or condensate causing intermittent, partial obstruction.
No. | Waveform detail | Does flow reach zero ? |
Any flow reversal ? |
Shape cue | Principal mechanism | Main consequence |
---|---|---|---|---|---|---|
1 | Prolonged tail gradually decays | X (approaches but above) | X | Gentle slope >1 s | High time-constant lungs (COPD/asthma) | Progressive air-trapping, rising auto-PEEP |
2 | New breath starts while flow still positive | X (clear gap from baseline) | X | Sharp “cut-off” by next inspiration | Expiratory time too short | Established auto-PEEP >2 cmH2O above set |
3 | Brief mid-expiratory spike upward | — | ✔ (negative→positive) | Narrow peak in exhalation limb | Premature patient effort retriggers breath | Trigger asynchrony (“fighting”) |
4 | Long, flat low-flow plateau then sudden drop | X (plateau above zero) | X | “Shelf” at ≈0.1–0.2 L·s-1 | Dynamic small-airway collapse (emphysema) | Air-trapping despite adequate expir-time |
Pattern 1 shows a gradual decay that merely suggests impending air-trapping; pattern 2 proves the trap has already occurred because inspiration interrupts active exhalation. Total-PEEP measurement confirms the difference.
Pattern 3 is defined by flow reversal—a spike crossing zero as the patient tries to inhale; pattern 4 never reverses but instead stalls at a low flow owing to airway collapse. The former is solved by trigger tuning, the latter by judicious extrinsic PEEP.
- Lengthen expiratory time (↓ RR or adjust I:E ratio) to allow complete exhalation.
- Apply extrinsic PEEP judiciously to counteract dynamic airway collapse without aggravating hyperinflation.
- Suction and humidify to eliminate saw-tooth patterns caused by secretions.
- Optimise trigger settings (flow or pressure sensitivity, trigger delay) to prevent premature inspiratory spikes.
- Monitor PaCO2, end-tidal CO2, and total PEEP; adjust ventilation strategy when values climb.
Written on June 7, 2025
Normal symmetry: Inspired tidal volume (VTi) matches exhaled tidal volume (VTe) within ≈10 %. The volume-time trace returns to baseline before the next breath, forming uniform rectangles on the scalar display.
A persistent gap between inspired and expired volume indicates gas escaping the system.
The expiratory limb fails to return to zero before the next inspiration, causing the trace to “ride” progressively higher.
Two mandatory breaths delivered in rapid succession without an expiratory phase create a two-step inspiratory limb and a single, larger expiratory descent.
Both inspiratory and expiratory tracings plummet to zero suddenly and remain flat.
Fine oscillations decorate the expiratory limb, mirroring saw-tooth flow patterns.
Pattern | VTi vs. VTe | Baseline return |
Distinctive shape cue | Primary mechanism |
---|---|---|---|---|
Volume loss | VTe < VTi | Yes | Gap between limbs, downward drift | Cuff / circuit leak |
Auto-PEEP | Nearly equal | X (elevated) | Cumulative baseline rise | Incomplete exhalation |
Breath stacking | VTi increases ≫ VTe (initially) | Delayed | Two-step inspiratory plateau | Double triggering |
Disconnection | 0 / flat | n/a | Sudden flat-line | Circuit break / massive leak |
Secretions artifact | Equal | Yes | Serrated expiratory limb | Mucus / condensate |
- Confirm cuff integrity (pilot-balloon pressure, cuff leak test) for VTe < VTi.
- Perform an expiratory hold to quantify total PEEP when baseline fails to return to zero.
- Adjust trigger sensitivity or sedation level to stop breath stacking.
- Reconnect or replace circuit immediately if a flat-line appears.
- Suction airway and drain humidifier to remove serrated artifacts.
Written on June 7, 2025
Volume-controlled (VC) breaths deliver a preset tidal volume by using a square-wave inspiratory flow. Depending on whether the ventilator allows the patient to draw additional (“adaptive”) flow above the square baseline—or replaces the baseline with a decelerating pattern—the breath is classified as assist/control mandatory ventilation (ACMV), controlled mechanical ventilation (CMV), or pressure-regulated volume control (PRVC).
Flow adaptation denotes the ventilator’s ability to sense negative deflection in airway pressure or inspiratory effort and deliver extra flow above the programmed constant value, thereby meeting the patient’s instantaneous demand without altering the target tidal volume.
When the patient initiates a stronger inspiratory effort during a square-wave VC breath, the ventilator permits a transient upward inflection in the flow waveform. This additional flow maintains patient comfort, shortens inspiratory muscle work, and prevents the pressure–time curve from dipping below baseline. Trigger sensitivity must remain high enough to capture spontaneous effort yet low enough to avoid auto-cycling.
In CMV the flow waveform is rigidly constant; the ventilator ignores any further negative pressure generated by the patient after the first trigger. The square-wave remains flat, so dyssynchrony may occur if inspiratory demand exceeds the programmed flow. This mode is suitable for deeply sedated or pharmacologically paralysed patients in whom spontaneous effort is undesirable (e.g., during acute lung recruitment or intracranial pressure control).
PRVC targets a set tidal volume but controls pressure rather than flow. The ventilator measures the compliance on each breath, then computes the minimal inspiratory pressure needed to achieve the volume while imposing a decelerating flow pattern. Peak inspiratory pressure is automatically adjusted—typically within a ±3 cm H2O window—to reach the volume goal with the lowest feasible pressure.
When a ventilator lacks a dedicated PRVC mode, selecting a decelerating flow option under VC partially reproduces PRVC’s gentler pressure profile; however, pressure is no longer actively regulated and peak variations may grow if compliance changes abruptly.
PRVC is a closed-loop “hybrid” mode that guarantees a set tidal volume (VT) while automatically choosing the lowest possible inspiratory pressure on every breath. The ventilator delivers a decelerating flow waveform—similar to pressure control (PC)—which spreads the flow early and tapers it late, lowering peak inspiratory pressure (Ppeak) compared with square-flow volume control (VC).
VC | PRVC | PC |
---|---|---|
Volume target | Volume target with adaptive pressure | Pressure target |
Square flow | Decelerating flow → lower Ppeak | Decelerating flow |
Upper-pressure alarm terminates the breath early, often yielding a small VT | Controller raises pressure to avoid lost VT yet stays below the limit | Pressure is fixed; VT falls if compliance worsens |
Clinical tip. Set the maximum pressure limit high enough (but safe) so PRVC can “do its job” in stiff lungs—commonly 5–7 cm H2O above your plateau-pressure goal. Then trend both Ppeak and exhaled VT to catch rising pressures or falling volumes early.
PRVC is a closed-loop hybrid mode designed to deliver a clinician-selected tidal volume while capping airway pressure on every breath. The ventilator begins with a test breath, measures dynamic compliance, and then calculates the minimum inspiratory pressure required to achieve the target volume using a decelerating flow waveform. On subsequent breaths it compares the exhaled tidal volume against the set point and automatically adjusts the inspiratory pressure—typically in ±3 cm H2O increments—until the volume target is met. Because flow decelerates, most of the breath is spent near the calculated peak pressure, yielding a pressure–time profile that resembles pressure control (PC), yet the controlling objective remains volume delivery, classifying PRVC as a volume-controlled strategy at its core.
The principal motivation for PRVC is to fuse the lung-protective advantages of PC (lower peak and plateau pressures, decelerating flow) with the metabolic certainty of a guaranteed tidal volume. This makes the mode attractive for patients whose compliance fluctuates rapidly—such as those with early acute respiratory distress syndrome, evolving pulmonary oedema, or post-operative atelectasis—where conventional VC risks pressure spikes and pure PC risks under-ventilation. However, PRVC can up-titrate inspiratory pressure to its safety ceiling if compliance deteriorates, potentially masking clinical decline; conversely, vigorous spontaneous effort may cause the algorithm to undershoot delivered volume.
Operator-controlled inputs are the target tidal volume, respiratory rate, inspiratory time (or I:E ratio), PEEP, and a maximum allowable pressure limit. The ventilator responds by modulating inspiratory pressure—and therefore peak flow—breath-by-breath, while maintaining the decelerating flow waveform typical of PC. The result is a mode that “looks and feels” like pressure control at the bedside, yet behaves as volume control under the hood, continuously trading small pressure adjustments for precise volume assurance.
Feature | ACMV (VC + adaptive flow) |
CMV (VC + fixed flow) |
PRVC (pressure-regulated VC) |
---|---|---|---|
Primary control variable | Volume | Volume | Pressure (for volume goal) |
Flow waveform | Square with upward spikes when patient inhales harder | Square, no deviation | Decelerating from an initial peak |
Peak inspiratory pressure (PIP) |
May rise if extra flow is large | Fixed; rises only with resistance/compliance change | Auto-adjusted breath-to-breath; generally lower than ACMV/CMV |
Best clinical fit | Spontaneously breathing, lightly sedated patients | Paralysed or deeply sedated patients | Patients with variable compliance who need lung-protective volumes |
Risk of dyssynchrony | Low | High if demand exceeds flow | Low (variable pressure + flow) |
Written on June 7, 2025
A mechanical breath begins when the ventilator detects patient effort through either a pressure trigger (drop below baseline circuit pressure) or a flow trigger (deflection of a continuous bias flow). Trigger sensitivity determines how much patient effort is required—less negative pressure or smaller flow reduction signifies a more sensitive trigger.
With pressure triggering the ventilator monitors circuit pressure relative to set PEEP. Inspiration is delivered when airway pressure falls by at least the trigger threshold \(\Delta P_{\text{trig}}\).
\[ P_{\text{aw}} \le P_{\text{EEP}} - |\Delta P_{\text{trig}}| \]
Figure. (1) With the trigger threshold set at −10 cm H₂O and PEEP at 7 cm H₂O, the patient-generated drop of −7 cm H₂O is insufficient to initiate a breath. (2) Reducing the threshold to −2 cm H₂O renders the ventilator sensitive enough to recognise the same effort and deliver inspiration.
Flow triggering employs a constant bias flow—commonly 2 L·min−1 in adults, 0.5 L·min−1 in paediatrics—and recognises inspiration when a portion of that flow is diverted into the patient.
\[ F_{\text{trig}} = F_{\text{bias}}\!\left(1 - \frac{S}{10}\right) \]
where \(F_{\text{trig}}\) is the flow drop that activates the breath and \(S\) is the sensitivity setting (0–10).
Sensitivity setting \(S\) | Drop required (\(F_{\text{trig}}\)) with 2 L·min−1 bias flow | % of bias flow diverted |
---|---|---|
2 | 1.6 L·min−1 | 80 % |
5 | 1.0 L·min−1 | 50 % |
8 | 0.4 L·min−1 | 20 % |
Written on June 7, 2025
In volume-controlled (VC) ventilation, the clinician fixes the tidal volume and allows the ventilator to generate a square (constant) inspiratory flow to deliver that volume within the preset inspiratory time. Because the flow trace is flat, the entire inspiratory period is actively filling the lungs unless an explicit inspiratory pause (T-pause) is inserted at the end of inspiration. When a pause is added—commonly 10 % of the total cycle time—the active-flow window shortens while the delivered volume remains unchanged; the ventilator therefore compensates by increasing instantaneous flow, which in turn elevates peak inspiratory pressure (Ppeak). Minute ventilation (ĖV) under VC follows the direct proportionality ĖV = VT × RR, so any adjustment to respiratory rate (RR) or tidal volume (VT) alters global carbon-dioxide clearance, whereas changes in pause fraction mainly influence alveolar pressure dynamics and airway stress.
Pressure-controlled (PC) ventilation, by contrast, targets a constant airway pressure rather than a fixed volume. The inspiratory flow automatically decelerates as the lungs fill, reaching near-zero toward the end of inspiration; this intrinsic taper means there is effectively no need for an additional T-pause. For a given compliance, PC can achieve the same tidal volume as VC while maintaining a lower Ppeak, thereby reducing the risk of barotrauma in patients with stiff or injured lungs. Using the illustrative VC settings RR = 15 breaths·min-1 (Tcycle = 4 s), I:E = 1:2 (ideal inspiratory window ≈ 1.33 s), and T-pause = 10 % (0.40 s), the active-flow time contracts to 0.93 s; reproducing the same volume in that shorter span demands a steeper flow ramp and raises Ppeak. In PC mode the flow would simply taper earlier without an imposed pause, keeping airway pressures lower while preserving the delivered volume—provided that inspiratory time is long enough to reach the pressure target.
➤ In pressure-controlled ventilation there is no separate T-pause. Once the set driving pressure (Pcontrol above PEEP) is reached, flow passively decelerates to near-zero, so the plateau pressure you observe is simply Ppeak = PEEP + Pcontrol. Any sudden change that increases airway resistance or decreases compliance—such as retained secretions—will cause the delivered tidal volume to fall at the same pressure target. For this reason, vigilant tidal-volume monitoring is essential in PC mode; a downward drift should prompt suctioning, bronchodilation, or adjustment of Pcontrol / Ti to re-establish adequate ventilation.
(1) T-pause 10 % (0.40 s, Ppeak 29 cmH2O); (2) T-pause 5 % (0.20 s, Ppeak 27 cmH2O); (3) T-pause 0 % (0 s, Ppeak 26 cmH2O). All examples use RR 15 breaths·min–1 (cycle time 4 s) and the same tidal volume. As the inspiratory pause lengthens, the active-flow segment of inspiratory time (Ti) contracts, requiring a steeper flow ramp to deliver the preset volume and thus elevating peak inspiratory pressure. A moderate pause remains valuable for plateau-pressure measurement and alveolar recruitment despite the higher Ppeak.
Given an operator-selected I:E ratio (\(I:E\)) and pause fraction \(P\) (decimal):
\[ \begin{aligned} T_{\mathrm i} &=T_{\text{cycle}}\times\frac{I}{I+E},\\ T\text{-pause} &=P\times T_{\text{cycle}},\\ T_{\mathrm{i,flow}} &=T_{\mathrm i}-T\text{-pause}. \end{aligned} \]
\(RR = 15\), \(I:E = 1:2\), \(P = 0.10\)
Computes total inspiratory time (Ti), the active-flow segment (Tiflow), and the pause plateau from respiratory rate (RR), a single I:E ratio expressed as 1:E, and a user-defined T-pause percentage.
The total inspiratory time (Ti) sets the window for volume delivery. A brief T-pause raises mean alveolar pressure and allows plateau-pressure measurement, but an excessive pause shortens the active-flow segment and can elevate peak inspiratory pressure or encroach on expiratory time.
\(T_{\text{cycle}} = \dfrac{60}{RR}\)
\(T_{\mathrm i} = T_{\text{cycle}}\times \dfrac{1}{1+E}\)
\(T_{\text{pause}} = P \times T_{\text{cycle}}\)
\(T_{\mathrm{i,flow}} = T_{\mathrm i} - T_{\text{pause}}\)
Aspect | VC | PC |
---|---|---|
How Ti is set | Indirect (via I:E, RR, P) | Directly entered or kept constant by machine |
Presence of T-pause | Explicit, user-defined (%) | Implicit; flow decays to ≈0 by end-inspiration |
Effect of ↑P on Ti | Ti unchanged; \(T_{\mathrm{i,flow}}\) shortens | Ti increases only if clinician extends it |
Impact on \(P_{\text{peak}}\) | Rises (higher constant flow rate) | Unaffected (pressure-targeted) |
Written on June 7, 2025
Written on June 7, 2025
Pressure-support (PS) and continuous positive airway pressure (CPAP) represent the least mandatory forms of mechanical assistance. These modes permit the patient to determine respiratory rate and—with appropriate settings—optimize comfort while maintaining adequate gas exchange. A safety net is provided by an apnea back-up algorithm that automatically delivers pressure-controlled (PC) breaths if spontaneous effort ceases.
When no spontaneous trigger is detected within the pre-set apnea time (factory default 20 s but adjustable, e.g. 15 s in the alarm profile), the ventilator converts to a PC back-up pattern until patient effort resumes.
Even during back-up PC, the pressure limit should be set high enough to enable protective tidal volumes but low enough to avoid barotrauma.
Setting pressure support above PEEP to 0 cm H2O converts the circuit to pure CPAP. The ventilator then provides only the selected PEEP and oxygen concentration, relying entirely on the patient’s inspiratory effort for tidal ventilation. Back-up PC remains available should apnea occur.
PS lacks an I:E ratio; instead, inspiratory cycle-off governs inspiratory time (TI) relative to total breath duration (Ttot). The ventilator switches to exhalation when inspiratory flow decays to a defined fraction of its peak.
Cycle-off setting | Effect on timing | Typical clinical cue |
---|---|---|
70 % | Very early termination; shortest TI | Corrects late-inspiratory pressure spikes (patient attempts exhalation) |
30 % (default) | Balanced TI / Ttot | General use; adjust as compliance or demand changes |
1 % | Very late termination; longest TI | Extreme restrictive physiology when larger tidal volume is required |
Circuit leaks (e.g., reduced cuff pressure) sustain elevated flow throughout inspiration, preventing decay to the cycle-off threshold and unintentionally prolonging TI. When compensation raises the effective threshold above the set value, the cycle-off percentage should be increased to restore timely exhalation.
Inspiratory cycle-off effects in PS mode.
(1) Default cycle-off 30 % of peak flow.
(2) Cycle-off 70 % → earlier switch to exhalation.
(3) Cycle-off 1 % → prolonged inspiration, larger tidal volume.
(4) Cycle-off set to 30 % but cuff pressure falls; compensation elevates effective threshold (≈40 %), lengthening inspiration—raise the setting above 40 % to restore timing.
(5) Late-inspiratory “fighting” produces an end-inspiratory pressure spike; increasing cycle-off shortens TI and resolves the dyssynchrony.
Written on June 8, 2025
Pressure-regulated volume control (PRVC) is a hybrid mode of mechanical ventilation that combines the advantages of volume control (VC) and pressure control (PC). A target tidal volume (VT) is delivered while the ventilator continuously adapts the inspiratory pressure on a breath-by-breath basis, using a decelerating (ramp-down) flow pattern. This strategy aims to minimize peak inspiratory pressure (PIP) and improve patient–ventilator synchrony.
PRVC employs an adaptive software loop:
This closed-loop approach preserves volume assurance while always seeking the lowest effective pressure.
Mode | Control variable | Inspiratory flow | Primary target | Typical PIP | Adaptive to compliance / resistance |
---|---|---|---|---|---|
VC | Volume | Constant | Set VT | Highest | No |
PC | Pressure | Decelerating | Set Pinsp | Lower | Partial (pressure fixed) |
PRVC | Volume via adaptive pressure | Decelerating | Set VT with minimal Pinsp | Lowest feasible | Yes (breath-to-breath) |
Written on June 19, 2025
When using a pneumatic jet nebulizer in respiratory therapy, it's crucial to consider its impact on mechanical ventilation parameters. (1) First, introducing a jet nebulizer can significantly increase the flow within the ventilatory circuit, which in turn may inadvertently raise the tidal volume (TV) delivered to the patient. This increase can lead to unexpectedly high lung volumes, risking volutrauma if not closely monitored and adjusted. (2) Additionally, this extra flow can cause a slight increase in airway pressure. While generally mild, this increase requires careful monitoring to prevent potential adverse effects on patients with compromised lung function or those at risk of barotrauma.
(3) Another consideration is the effect on the fraction of inspired oxygen (FiO2). The use of a jet nebulizer can dilute the oxygen concentration within the ventilatory circuit as air is utilized to nebulize the medication, resulting in a reduced FiO2. Adjusting the oxygen settings to compensate for this dilution is essential to ensure that the desired level of oxygenation is maintained. (4) Furthermore, the additional flow and pressure fluctuations introduced by the nebulizer can interfere with the ventilator's sensitivity settings, complicating the initiation of spontaneous breathing by the patient. This may increase the work of breathing and lead to discomfort or fatigue. To mitigate these effects, it may be necessary to adjust the trigger sensitivity settings on the ventilator to lower the threshold required for triggering, thereby reducing the respiratory effort needed from the patient.
High Airway Pressure (Paw) Alarm: This alarm can be triggered by increased airway resistance or decreased lung compliance. To reduce airway resistance, perform suctioning and administer nebulized treatments. If the issue is related to lung compliance, consider interventions such as inhaled nitric oxide or extracorporeal membrane oxygenation (ECMO) to enhance lung flexibility and functionality.
Decreased Oxygen Saturation: When decreased oxygen saturation is detected, indicated by alarms or monitoring systems, several critical steps must be taken to ensure optimal patient care. Oxygen levels are primarily monitored using SpO2 and arterial oxygen partial pressure (PaO2). Immediate actions include resolving any High Paw Alarm by suctioning and nebulization to decrease airway resistance. It is also vital to thoroughly check the ventilatory circuit for any disconnections or leaks, as these can significantly compromise the oxygen delivery system.
To assess the patient's oxygenation status more comprehensively, performing an arterial blood gas analysis (ABGA) is recommended to check PaO2 levels. Based on these results, adjustments to the fraction of inspired oxygen (FiO2) and positive end-expiratory pressure (PEEP) should be considered. Initially, FiO2 may be increased to deliver more oxygen, especially in acute settings. Concurrently, adjusting PEEP can help improve oxygenation and ensure the patient receives adequate oxygen while preventing potential lung damage.
A practical approach involves starting with higher FiO2 and PEEP settings and then gradually reducing them as the patient's condition stabilizes or improves. For example, beginning with an FiO2 of 100% paired with a PEEP of 12 cm H2O, and methodically lowering both to potentially an FiO2 of 30% and a PEEP of 5 cm H2O as the patient's oxygenation status allows. This systematic and intuitive adjustment process is aligned with the ARDSnet protocol guidelines, which provide extensive tables and further recommendations for managing FiO2 and PEEP in different clinical scenarios.
High Carbon Dioxide Levels (PaCO2): If this alarm activates, first assess whether increased airway resistance is contributing to inadequate CO2 removal. To enhance CO2 clearance, adjust the tidal volume (TV) upwards. Increasing the respiratory rate (RR) can also help by augmenting the overall ventilation. Another strategy is to modify the inspiratory to expiratory ratio (I:E Ratio), which can improve ventilation efficiency. However, care must be taken to ensure that these adjustments do not lead to air trapping, especially in patients with conditions like Chronic Obstructive Pulmonary Disease (COPD).
PEEP High Alarm Due to Filter Obstruction: A 'PEEP High Alarm' in mechanical ventilation typically signals a blockage in the expiratory phase, often due to a clogged filter that impedes the flow of expired air, leading to increased end-expiratory pressure. The crucial step in troubleshooting is to promptly remove the filter to check if it is the source of the obstruction. If removing the filter resolves the alarm and normal ventilation function is restored, this confirms the filter as the culprit. The immediate replacement of the obstructed filter is critical to maintain unimpeded airflow, ensuring the ventilation system operates efficiently and safely.
Management of Expiratory Filters: Expiratory filters are critical in managing airway resistance within mechanical ventilation systems. These filters usually last one to two days, though high-quality, genuine filters can remain effective for up to five days under ideal conditions. Obstructions in these filters are common and can be caused by various factors, including the administration of specific medications such as colistin and coagulants, or due to excessive nebulization. When filter issues are suspected, such as after administering colistin, it is advisable to perform routine checks and ensure timely maintenance or replacement of the filters to maintain optimal ventilation management.
Strategic Use of PEEP in Patients with V/Q Mismatch and Shunting: For patients exhibiting V/Q mismatch or shunting, often caused by lung infiltration as indicated by a chest X-ray, increasing the positive end-expiratory pressure (PEEP) can enhance their condition by improving oxygenation and reducing shunt effects. However, if the PEEP exceeds 10 cm H2O, it may lead to decreased venous return, potentially resulting in hemodynamic instability. In such scenarios, administering an inotrope may be necessary to help maintain or increase blood pressure.
Auto-PEEP Detection and Management (Version I): Auto-PEEP is a significant concern, particularly in patients receiving medications such as colistin or anticoagulants, which can increase the risk of this complication. Monitoring the end-expiratory flow, known as V̇ee on a Servo ventilator, is critical because an increase in V̇ee may indicate the presence of Auto-PEEP, necessitating prompt assessment and intervention to ensure optimal ventilator function and patient safety.
Effective management of Auto-PEEP includes adjusting the inspiratory to expiratory (I:E) ratio, for example, from 1:2 to 1:3. This adjustment extends the expiratory time relative to the inspiratory time, aiming to provide sufficient expiratory time — ideally more than three times the time constant (Tc). This strategy promotes complete exhalation, prevents lung overdistension, optimizes respiratory mechanics, and aids in preventing complications such as air trapping while ensuring efficient CO2 removal. Maintaining the inspiratory time (Ti) within 0.6 to 1.2 seconds, even when altering the I:E ratio, is essential to avoid negative impacts on the patient's breathing pattern.
In scenarios where there is a rapid increase in respiratory rate (RR), continuous monitoring of V̇ee through the "Trends" function on the ventilator is essential. This allows clinicians to observe changes over time and make informed decisions about ventilatory adjustments. Additionally, performing an arterial blood gas analysis (ABGA) is routine to check for CO2 retention and decreased O2 levels, further informing the adjustment process.
Further strategies to manage Auto-PEEP include ensuring clear airways and, if necessary, adjusting the respiratory rate (RR) and tidal volume (TV). Encouraging patients to take deep breaths can help decrease the buildup of intrinsic PEEP and facilitate better lung decompression. Additionally, adjunctive therapies such as nebulization, the administration of steroids, or bronchoscopy may be necessary to address underlying respiratory issues contributing to Auto-PEEP.
Air Trapping Indicators and Management (Version II): Air trapping, commonly seen in conditions like COPD, asthma, or airway edema, manifests through several indicators:
Air Flow Reductions: In scenarios where there is inspiratory pressure but the airflow drops to zero, urgent assessment and management are crucial to identify and rectify underlying causes. This issue often points to problems with lung compliance or mechanical impediments in the ventilation system. Evaluating lung elasticity is essential, and it's important to ensure that inspiratory pressures are not excessively high, as this could exacerbate lung stiffness and compromise function.
In terms of mechanical causes, obstructions in the endotracheal tube (ET tube) should be checked. Such obstructions can be due to kinking, blockage within the tube, or from the patient biting the tube. Inspecting and, if necessary, replacing the ET tube is crucial. If the patient is biting the tube, using a bite block can prevent occlusion and ensure continuous airflow. Addressing these issues promptly is vital not only to restoring proper airflow but also to preventing potential lung damage from inadequate ventilation.
Additionally, understanding lung compliance through static and dynamic indices can provide insights into lung health and guide appropriate ventilatory support. Static Compliance (Cstat) is calculated from the formula VTe / Pplat - PEEP, where VTe is the exhaled tidal volume, Pplat is the plateau pressure after an inhalation pause, and PEEP is the positive end-expiratory pressure, with normal values ranging from 60 to 100 ml/cm H2O. A value below this range indicates increased lung stiffness. Dynamic Compliance (Cdyn), calculated as VTe / EIP - PEEP, where EIP is the end-inspiratory pressure, typically ranges from 50 to 80 ml/cm H2O. Values below 30 ml/cm H2O suggest severe lung conditions such as Acute Respiratory Distress Syndrome (ARDS). Monitoring these indices helps in fine-tuning ventilatory settings to optimize patient care and outcomes.
Measures lung compliance without the influence of airway resistance.
Cstat = VT / (Pplat − PEEP)
Where Pplat is Plateau Pressure and PEEP is Positive End-Expiratory Pressure.
Dynamic compliance is measured during airflow and includes resistance.
Cdyn = VT / (Ppeak − PEEP)
Where Ppeak is Peak Inspiratory Pressure and PEEP is Positive End-Expiratory Pressure.
An elevated airway-pressure alarm reflects either increased resistance (secretions, tube kinking, bronchospasm) or diminished compliance (pneumothorax, pulmonary oedema, acute respiratory distress syndrome). A tiered, protocol-driven response preserves lung integrity and forestalls secondary alarms.
PIP explained. Peak inspiratory pressure is the highest airway pressure recorded during inspiration.Maintaining PIP ≤ 30–32 cm H2O mitigates barotrauma risk.
- In pressure-controlled modes, PIP = PEEP + preset inspiratory pressure.
- In volume-controlled modes, PIP comprises PEEP plus resistive and elastic pressure components needed to deliver flow.
Persistent high airway pressure may truncate tidal delivery or trigger premature cycling, precipitating a low expiratory minute-volume alarm.
Alarm | Probable mechanism | Typical clues | Core intervention |
---|---|---|---|
Paw high | ↑ Resistance or ↓ Compliance | Spiking pressure curve, unchanged VT | Suction, tube adjustment, bronchodilator, compliance work-up |
Minute volume low | Leak or hypoventilation after unresolved Paw high | Hissing sounds, low expired VT | Seal leak, ↑ VT/PIP/RR, re-verify cuff |
Written on June 7, 2025
Managing a patient with ALS experiencing dyspnea necessitates a nuanced approach to both immediate and long-term respiratory support strategies. An effective initial strategy often includes adjusting the Inspiratory Positive Airway Pressure (IPAP) in Spontaneous/Timed (ST) mode, for example, increasing it from 13 to 15 cm H2O. This adjustment can enhance alveolar ventilation by increasing the tidal volume, potentially alleviating symptoms of dyspnea and reducing the patient's respiratory effort. Such strategic management is essential in addressing progressive neuromuscular conditions like ALS, where muscle weakness can intensify over time, escalating the patient's respiratory workload.
If the patient's dyspnea persists and there is an inclination to remove the ventilator, it might indicate a conflict during inspiration when the patient attempts to exhale. In such scenarios, it is crucial to consider adjusting or increasing the "Cycle" setting of the ST mode from the current 25% gradually upwards. This adjustment can help synchronize the ventilator more closely with the patient's natural breathing cycle, potentially reducing the sensation of fighting the ventilator and improving comfort.
Continuous assessment is crucial to determine if further adjustments or a switch in ventilation mode might offer additional benefits. In cases where adjustments to IPAP alone are insufficient for managing symptoms effectively, or when concerns arise regarding patient comfort and ventilator synchrony, exploring other modes such as BiPAP or CPAP may be warranted.
BiPAP is particularly beneficial due to its capability to independently control both IPAP and EPAP, allowing for customized support during both inhalation and exhalation phases. Unlike ST mode, which primarily focuses on maintaining a minimum number of breaths per minute with less flexibility, BiPAP facilitates dynamic adjustments that can more precisely respond to the patient's varying respiratory needs throughout the day or as their condition changes. This refined approach to respiratory support is especially advantageous in ALS, where patients may experience fluctuating respiratory efforts.
Furthermore, BiPAP can enhance patient-ventilator synchrony by independently and precisely adjusting IPAP and EPAP. This adjustment improves synchrony with the patient's natural breathing cycle, potentially reducing asynchrony and increasing comfort — critical factors for patients who can still initiate breaths but whose respiratory strength may vary. The versatility of BiPAP extends to periods of sleep or varying levels of respiratory muscle fatigue, making it an optimal choice for maintaining comfort and effective ventilation across different states of patient activity and rest.
Pressure Support (PS) mode offers another viable option for patients capable of initiating breaths independently but who require assistance to maintain adequate ventilation. PS mode supports the patient's breathing effort by providing a preset level of pressure support during inhalation, terminated based on the patient's inspiratory flow, thus facilitating a more natural breathing pattern. This mode significantly enhances patient-ventilator synchrony and comfort, particularly beneficial for conscious patients with fluctuating respiratory drive.
Conversely, Continuous Positive Airway Pressure (CPAP) maintains a constant pressure throughout the respiratory cycle. This mode might not suit ALS patients requiring active assistance with inhalation due to muscle weakness. CPAP is generally more appropriate for patients who can maintain adequate spontaneous breathing efforts and primarily need support in keeping their airways open.
Ultimately, the decision to adjust IPAP within ST mode or to transition to another mode such as BiPAP or PS should be driven by ongoing evaluations of the patient's respiratory status, including blood gas analyses and symptom assessment. Regular re-evaluation and close monitoring are essential to ensure that the ventilatory support continues to meet the evolving needs of the ALS patient, striving to achieve an optimal balance of adequate ventilation, patient comfort, and minimal respiratory effort. This comprehensive approach ensures that respiratory management is both effective and adaptable, providing tailored support that evolves with the patient's condition.
Guardian consent obtained for IRB-approved clinical research aimed at disseminating better clinical practices in hemodynamics.
In managing respiratory distress in patients using BiPAP ventilation, specific adjustments are essential for those showing signs of hypoventilation and CO2 retention. Typically, these patients demonstrate reduced tidal volumes (Vt) of 150-250 mL, with arterial blood gas (ABGA) analyses indicative of mild respiratory acidosis, typically with a pH slightly below the normal range of 7.35-7.45, and elevated PCO2 slightly above the normal range of 35-45 mmHg. Bicarbonate levels may also be at the upper end of the normal range (22-28 mEq/L), indicating renal compensation. Additionally, an elevated PO2 well above the normal range for room air (75-100 mmHg) suggests the use of supplemental oxygen therapy, which is crucial for managing hypoxemia but requires careful monitoring to avoid complications associated with hyperoxia.
Rationale for Increasing IPAP: An increase in IPAP, for example from 13 to 15 cm H2O, is strategically implemented to enhance alveolar ventilation and improve CO2 clearance. This intervention is essential as it directly increases tidal volume, promoting deeper breaths that not only help in recruiting more alveoli for gas exchange but also effectively eliminate excess CO2.
Reasoning for Lowering Oxygen Supply: Even with stable SpO2 levels above 92%, reducing supplemental oxygen is crucial to prevent oxygen toxicity and hyperoxia, which could suppress respiratory drive — particularly harmful in conditions predisposing to CO2 retention. Adjusting oxygen delivery to maintain SpO2 just above 92% ensures sufficient oxygenation without compromising the patient's inherent respiratory efforts, thereby supporting natural respiratory mechanisms and enhancing overall respiratory function.
Necessity of Manual Adjustment of IPAP: Despite the dynamic capabilities of BiPAP machines to adjust IPAP and EPAP, manual intervention is often required. Automatic adjustments might not always perfectly align with rapidly changing or unique clinical situations due to limitations in preset algorithms. Manually increasing IPAP allows healthcare providers to fine-tune ventilatory settings based on real-time patient responses and specific ventilation goals, ensuring that the therapeutic approach is precisely tailored to achieve optimal outcomes. This level of customization is crucial for effectively managing acute respiratory distress and provides significant advantages over more rigid modes like ST, which are less adaptable to patient-specific needs.
Guardian consent obtained for IRB-approved clinical research aimed at disseminating better clinical practices in hemodynamics.
Home Ventilator Application Status - Chronic CO2 retention and respiratory acidosis - Compensatory metabolic alkalosis - December 22, 2023: BiPAP initiated - December 29, 2023: Due to diaphragmatic dysfunction, home ventilator initiated in SIMV-PS mode Tidal Volume (TV): 300–350 mL Inspiratory Pressure (Pi): 10–15 cmH2O Respiratory Rate (RR): 16 breaths/min - February 2024: Home ventilator adjusted (SIMV mode) Pressure (Pr): 13 cmH2O PEEP: 5 cmH2O RR: 15 breaths/min O2: 1 L/min - March 25, 2024: Changed to PSV mode Measured TV: ~300 mL Pressure Support (Pr): 12 cmH2O PEEP: 5 cmH2O RR: 15 → 14 breaths/min - November 8, 2024: PSV mode continued Measured TV: ~300 mL Pr: 12 cmH2O PEEP: 5 cmH2O RR: 14 breaths/min
The patient has chronic CO2 retention and a compensatory metabolic alkalosis, indicating a long-term respiratory failure scenario. Initial noninvasive management (BiPAP) was followed by a transition to a home ventilator setup due to diaphragmatic dysfunction. Over time, the ventilator mode evolved from SIMV with pressure support to PSV, reflecting changes in clinical strategy and attempts to balance stable support with partial patient-driven ventilation. Ultimately, the patient has maintained stability on a PSV configuration without further reductions in pressure support.
Documented Settings: BiPAP (Bilevel Positive Airway Pressure) initiated, but no exact pressures recorded.
Typical Variables Required:
Commentary: BiPAP provides two distinct pressure levels. At this stage, it was likely chosen to noninvasively support ventilation, reduce CO2 levels, and alleviate work of breathing. Precise IPAP and EPAP values would be necessary to fully reproduce the initial setup. The missing data here—such as exact pressure levels and O2—suggests incomplete information.
Documented Settings: SIMV-PS mode: TV ~300–350 mL, Pi 10–15 cmH2O, RR 16 (PEEP and exact FiO2/O2 unknown)
Typical Variables Required for SIMV-PS:
Commentary: Transitioning to SIMV suggests a need for more structured ventilatory support. Some parameters (PEEP, FiO2) are not documented here, making it hard to fully replicate the initial SIMV setup. The mention of Pi (Inspiratory Pressure) suggests a pressure-limited or pressure-supported component for spontaneous breaths.
Documented Settings: SIMV: Pr 13 cmH2O, PEEP 5 cmH2O, RR 15, O2 1 L/min
Typical Variables for SIMV-PS:
Commentary: By February, the documentation is more complete: a defined pressure support level (Pr 13 cmH2O) and PEEP (5 cmH2O) are stated, along with RR and O2 flow. This reflects a refinement in the ventilation strategy. The patient is still receiving partial mandatory support (SIMV) along with pressure support for spontaneous breaths. Although O2 is given as 1 L/min, the exact FiO2 remains unreported; still, this information is more sufficient for reproduction compared to December 29, 2023.
Documented Settings: PSV mode: Measured TV ~300 mL, Pr 12 cmH2O, PEEP 5 cmH2O, RR from 15 to 14
Typical Variables Required for PSV:
Commentary: Switching to PSV reduces mandatory breaths, relying on the patient’s inspiratory effort. Pressure Support (12 cmH2O) and PEEP (5 cmH2O) remain key settings. The measured tidal volume (~300 mL) and recorded RR (14) show patient-driven ventilation within supported parameters. Additional variables (exact FiO2, alarm settings) are not specified, but enough information is present to approximate the scenario.
Documented Settings: PSV mode: TV ~300 mL, Pr 12 cmH2O, PEEP 5 cmH2O, RR 14
Commentary: No change in support parameters since March 25, 2024. This long-term stability suggests the patient’s condition is neither deteriorating nor significantly improving toward lower support. The ventilator settings remain consistent, likely indicating chronic stable respiratory failure management.
Weaning from mechanical ventilation—whether invasive (via PSV reduction) or noninvasive (gradual reduction in IPAP/EPAP)—typically requires objective and subjective assessments. Common criteria and indices include:
By November 8, 2024, the patient remains stable on PSV at Pr 12 cmH2O and PEEP 5 cmH2O, with a tidal volume around 300 mL. To assess further weaning potential, it would be advisable to:
No attempts since March 2024 have been documented to reduce support from PSV 12 cmH2O to a lower level or to shift to a simpler mode (e.g., CPAP only) as a step toward extubation or liberation from mechanical ventilation.
For future monitoring, it would be prudent to consider:
If the patient tolerates reduced support (e.g., PSV 10 cmH2O or even transitioning to CPAP or minimal support), it may indicate readiness to attempt complete weaning or prolonged noninvasive support only (e.g., BiPAP at home if considered appropriate).
The Rapid Shallow Breathing Index (RSBI) is a clinical parameter used to assess the likelihood of successful weaning from mechanical ventilation. It relates a patient’s respiratory rate (RR) to their tidal volume (Vt), providing insight into respiratory efficiency and effort.
\[ \text{RSBI} = \frac{\text{Respiratory Rate (RR)}}{\text{Tidal Volume (Vt in liters)}} \]
If you must use VTi:
\[ \text{RSBI} = \frac{15}{0.35} \approx 42.9 \]
An RSBI of about 42.9 is well below the commonly accepted threshold of 105, suggesting that the patient may be ready to begin weaning from mechanical ventilation.
Guardian consent obtained for IRB-approved clinical research aimed at disseminating better clinical practices in hemodynamics.
Written on Decmeber 11, 2024
Mechanical ventilation modes such as Synchronized Intermittent Mandatory Ventilation (SIMV) allow both mandatory (ventilator-driven) and spontaneous (patient-driven) breaths. Clinicians often use pressure-based settings to control or support these breaths. However, handwritten and device-displayed ventilator settings can sometimes differ in terminology, causing confusion about parameters like IP (Inspiratory Pressure) and SP (Pressure Support). This document clarifies these terms and illustrates how they translate across different devices.
A frequently encountered example is a handwritten note reading:
SIMV | O2 2L | RR 16 | IP 8 | SP 8 | PEEP 5
1. SIMV
Synchronized Intermittent Mandatory Ventilation, a mode where a set number of breaths are delivered by the ventilator at a preset level, while allowing spontaneous breathing in between.
2. O2 2L
Represents an oxygen flow of 2 L/min. Depending on the ventilator model, this may correlate to a specific FiO₂ (Fraction of Inspired Oxygen).
3. RR 16
A mandatory breath rate of 16 breaths per minute.
4. IP 8 → "P control"
Often shorthand for Inspiratory Pressure (in pressure-controlled or assisted modes). In many SIMV modes, “IP” may be the pressure above PEEP delivered during each mandatory breath.
5. SP 8 → "PS"
Common shorthand for Pressure Support for spontaneous breaths. Helps reduce work of breathing by assisting patient-initiated breaths with an additional 8 cmH₂O of pressure.
6. PEEP 5
Positive End-Expiratory Pressure of 5 cmH₂O, preventing alveolar collapse at end-expiration and improving oxygenation.
In this handwritten example, both the mandatory breaths (IP 8) and spontaneous breaths (SP 8) receive a similar pressure level (8 cmH₂O above PEEP).
Later, the ventilator settings were checked on a ResMed device, which displayed:
Parameter | Value | Notes |
---|---|---|
Mode | P-SIMV | Pressure-Synchronized Intermittent Mandatory Ventilation. |
PC | 8.0 cmH₂O | Pressure Control, essentially the same concept as Inspiratory Pressure (IP). |
PEEP | 5.0 cmH₂O | Positive End-Expiratory Pressure. |
RR | 16 breaths/min | Number of mandatory breaths per minute. |
Ti | 1.20 seconds | Inspiratory time for each mandatory (ventilator-driven) breath. |
PS | 8 cmH₂O | Pressure Support, applied to spontaneous (patient-initiated) breaths. |
Rise Time | 200 ms | The duration it takes the ventilator to reach the set pressure. |
In this scenario:
Inspiratory Pressure (IP) / Pressure Control (PC)
Refers to the preset pressure for mandatory breaths. In pressure-controlled SIMV, the ventilator ensures each mandatory breath reaches this target pressure above PEEP.
Pressure Support (PS)
Augments spontaneous breaths initiated by the patient. Eases the patient’s work of breathing by providing extra pressure, helping overcome airway resistance and ventilator circuit resistance.
Ventilator settings vary based on patient condition, but the following ranges serve as general guidelines:
Parameter | Typical Range | Clinical Considerations |
---|---|---|
FiO₂ (or O₂ Flow) | 21–100% FiO₂ 2–15 L/min (if flow-based) |
Adjusted to achieve target oxygen saturation (e.g., SpO₂ ≥ 92%). |
Respiratory Rate (RR) | 10–20 breaths/min (can be 8–30) | Titrated based on blood gas analyses, pH, PaCO₂, etc. |
PEEP | 4–10 cmH₂O (sometimes 10–15 cmH₂O+ in ARDS or severe hypoxemia) |
Improves oxygenation by preventing alveolar collapse. |
Pressure Control (PC/IP) | 8–25 cmH₂O above PEEP | Lower levels (≈8–10 cmH₂O) for minimal support; higher for severe cases. |
Pressure Support (PS) | 5–15 cmH₂O | Chosen based on work of breathing and patient comfort. |
Inspiratory Time (Ti) | ~0.8–1.5 seconds | Ensures adequate tidal volume without causing air trapping. |
Rise Time | 50–300 ms | Affects how quickly pressure is delivered; personalized per patient. |
Guardian consent obtained for IRB-approved clinical research aimed at disseminating better clinical practices in hemodynamics.
Written on February 25, 2025
A patient with a prior stroke secondary to arrhythmia initially received anticoagulant therapy, followed by a hemorrhagic stroke, which required neurosurgical intervention. After an extended hospitalization (~140 days) with persistent deep drowsiness, the patient was transferred to the current facility on March 21, 2025 for continued neurological care, infection control, and ventilator weaning.
The patient has a tracheostomy with a T-tube (size 7.0). An auto-suction line—a specialized, often closed, suction system designed to reduce circuit breaks and minimize infection risk—is available. However, it is not currently used because previous episodes of aspiration pneumonia coincided with mealtime and feeding, leading the care team to opt for manual suctioning and more controlled airway management techniques.
The patient is managed using PSIMV (Pressure Synchronized Intermittent Mandatory Ventilation) with Pressure Support (PS) for spontaneous breaths. A Pressure Control (PC) backup ensures a minimum mandatory ventilation if the patient’s spontaneous rate or effort becomes insufficient.
Weaning Approach: In this mode, the focus is on gradually reducing Pressure Support. For example, from 10 cmH₂O to 8 cmH₂O, and then to 5 cmH₂O, provided the patient maintains adequate ventilation and stable vital signs.
Parameter | Current Setting | Typical/Normal Range | Target / Rationale |
---|---|---|---|
Ventilator Mode | PSIMV (ResMed) | N/A | Main mode for partial support; PC acts as backup |
Pressure Control (backup) | 10 cmH₂O | 8–20 cmH₂O (varies by lung condition) | Reduce if the patient consistently meets spontaneous ventilation |
Pressure Support (PS) | 10 cmH₂O | 5–15 cmH₂O | Key for weaning; decrement as tolerated |
PEEP | 5 cmH₂O | 5–10 cmH₂O | Maintain end-expiratory lung volume; can adjust for oxygenation |
Set Respiratory Rate | 12 breaths/min | 12–20 breaths/min (adult) | Ensures a minimal backup rate |
Measured Tidal Volume (Vti) | ~360 mL (0.36 L) | ~6–8 mL/kg PBW1 (≈400–600 mL) | Monitor for adequate alveolar ventilation |
Supplemental O₂ | 3 L/min (nasal cannula) | 1–6 L/min | Aim for SpO₂ ≥ 92% |
1 PBW = Predicted Body Weight
Lower PS from 10 cmH₂O to 8 cmH₂O, and subsequently to 5 cmH₂O if tolerated. Evaluate respiratory rate, tidal volume, oxygen saturation, and overall work of breathing.
Arterial Blood Gas Analysis (ABGA) remains the gold standard for assessing PaCO₂, PaO₂, and pH during weaning trials. If ABGA is not immediately available, rely on:
Continue the antibiotic regimen until clinical and radiological resolution of pneumonia. Optimize enteral feeding (600–900 mL/day) to maintain adequate nutrition without exacerbating respiratory effort or aspiration risk.
The patient’s husband remains the primary caregiver. Ongoing discussions about the risks, benefits, and timeline of ventilator weaning are essential to maintain trust and realistic expectations.
Guardian consent obtained for IRB-approved clinical research aimed at disseminating better clinical practices in hemodynamics.
Written on March 21, 2025
A patient has been transferred with a ventilator set to ACMV-PC (Assist-Control Mandatory Ventilation in Pressure Control) mode. The transfer document lists specific settings—PEEP 6 cmH₂O, Pi 10 cmH₂O, Rate 14 breaths/min, Ti 1.1 seconds, and a High Trigger—which invite a detailed examination of each parameter and a broader discussion comparing ACMV-PC to ResMed’s P(A)CV and P(A)C modes. The following sections provide a structured overview of these settings, their typical clinical ranges, and the rationale behind assist-control ventilation.
Mode | ACMV-PCV | ||
---|---|---|---|
PEEP | 6 cmH₂O | Pi | 10 cmH₂O |
Ti | 1.1 sec | Rate (bpm) | 14 |
Trigger | High |
The table below aligns the provided settings from the transfer document with typical clinical ranges used in practice. While these values are generally appropriate for many adult patients, they must be adjusted based on individual factors such as lung compliance, oxygenation requirements, and the patient’s spontaneous breathing effort.
Parameter | Provided Setting | Typical Range / Notes |
---|---|---|
PEEP | 6 cmH₂O | Commonly 5–15 cmH₂O (can be higher in ARDS). Maintains alveolar recruitment. |
Pi (Peak Inspiratory Pressure) | 10 cmH₂O | Often 10–20 cmH₂O (adjusted for lung compliance). Affects tidal volume and ventilation. |
Rate (RR) | 14 breaths/min | Typically 12–20 breaths/min for an adult. Set to ensure minimum ventilation. |
Ti (Inspiratory Time) | 1.1 seconds | Usually 0.8–1.2 seconds (adjusted per patient). Influences oxygenation and comfort. |
Trigger | High | Reflects ventilator sensitivity. High = reduced auto-trigger but requires stronger patient effort. |
Guardian consent obtained for IRB-approved clinical research aimed at disseminating better clinical practices in hemodynamics.
Written on March 27, 2025
A 90-year-old male patient was transferred with the following ventilator document entry:
Ventilator Transfer Document
- PC/AC → P(A)CV
- Frequency (set): 26 → RR
- Tidal Volume: 400 mL
- PEEP: 4 cmH₂O
- I:E Ratio: 1:1.9
- Inspiration Time: 0.8 seconds
↑ Settings ↑
↓ Measurements ↓
- VTi: 403 mL
- Minute Volume: 11.2 L/min
- Peak Pressure (Ppeak): 22.4 cmH₂O
The document includes both settings (e.g., pressure control, respiratory rate, PEEP) and monitored values (e.g., measured tidal volume, minute volume, peak pressure). The following outline explains each parameter, discusses the equivalent mode on a ResMed ventilator, and provides a table of typical normal ranges to guide clinical decision-making.
The list includes both configuration settings and measurements:
The following table provides general reference ranges. Actual targets must be tailored to each patient’s clinical condition, including lung mechanics, gas exchange requirements, and comorbidities.
Parameter | Typical Normal Range | Remarks |
---|---|---|
Respiratory Rate | 12–20 breaths/min | Can be higher (up to 20–30) if the patient requires increased ventilation (e.g., to correct hypercapnia). |
Tidal Volume | 6–8 mL/kg of predicted body weight | Often 400–600 mL in adults; focus on lung-protective ventilation to avoid volutrauma. |
PEEP | 5–10 cmH₂O | Typically started around 5 cmH₂O; titrate to improve oxygenation and prevent alveolar collapse. |
I:E Ratio | 1:2 (range 1:1.5–1:4) | Adjusted based on pathology (e.g., COPD may require prolonged expiration). |
Inspiratory Time | 0.8–1.2 seconds | Depends on desired I:E ratio and specific disease factors. |
Minute Ventilation | 5–10 L/min | Varies with metabolic demands; measured to ensure adequate CO₂ clearance. |
Peak Pressure | < 30 cmH₂O | Peak pressures above 30 cmH₂O may increase lung injury risk; must consider plateau pressure for more accuracy. |
When transferring these parameters to a ResMed ventilator, the following approach is recommended:
Guardian consent obtained for IRB-approved clinical research aimed at disseminating better clinical practices in hemodynamics.
Written on March 27, 2025
This case details a patient diagnosed with hypoxic encephalopathy who presented with myoclonic seizures. Pharmacological management included valproate, levetiracetam, and clonazepam, alongside sedative agents. While overt seizure activity subsided, persistent spasticity and a stuporous mental status remained.
Although the patient could initiate spontaneous breathing, intermittent apnea necessitated prolonged ventilatory support. Consequently, a tracheostomy was performed to secure the airway, maintain adequate ventilation, and mitigate the risk of aspiration. The discussion below concentrates on the ventilator settings reported, the indications for mechanical ventilation, and the rationale behind choosing Pressure Support Ventilation (PSV) over other modes.
Diagnosis
Respiratory Status
Airway Access
The ventilator settings are reported as:
“PSV, Above PEEP 9, PEEP 7, FiO₂ 25%”
The notation “Above PEEP 9, PEEP 7” indicates that the patient receives 9 cm H₂O of Pressure Support (PS) in addition to a Positive End-Expiratory Pressure (PEEP) of 7 cm H₂O. Hence, each inspiratory effort is assisted by 9 cm H₂O on top of the 7 cm H₂O baseline. The fraction of inspired oxygen (FiO₂) is set at 25%, suggesting a comparatively low supplemental oxygen requirement.
Patient’s Ventilator Settings | Value | Approximate Range |
---|---|---|
Ventilation Mode | PSV | |
Pressure Support (Above PEEP) | 9 cm H₂O | 5–20 cm H₂O |
PEEP | 7 cm H₂O | 5–10 cm H₂O |
FiO₂ | 25% | 21–100% (adjusted per ABG results) |
Mechanical ventilation was mandated based on neurologic compromise and respiratory insufficiency. In general, mechanical ventilation is considered when specific clinical or numerical thresholds are met:
Indication | Typical Criteria/Threshold |
---|---|
Apnea or Impending Respiratory Arrest | Absent or severely depressed respiratory drive |
Hypoxemia | PaO₂ < 60 mmHg on FiO₂ ≥ 0.50 |
Hypercapnia with Respiratory Acidosis | PaCO₂ > 50 mmHg and pH < 7.25 |
Inability to Protect the Airway | Diminished consciousness, high risk of aspiration |
Ventilatory Muscle Fatigue & Elevated Work of Breathing | RR > 35 breaths/min, rapidly rising PaCO₂ |
Neurological Factors | Severe stupor, inability to maintain consistent ventilatory effort (e.g., GCS < 8, repeated apnea episodes) |
In this patient:
A variety of modes—such as SIMV (Synchronized Intermittent Mandatory Ventilation) PC + PS, PSV, and BiPAP (Bilevel Positive Airway Pressure)—were assessed. Each mode differs in its level of control, synchronization, patient comfort, and reliance on spontaneous effort.
Parameter | SIMV PC + PS | PSV | BiPAP |
---|---|---|---|
Level of Control | Mandatory PC breaths + partial support | Patient-driven, pressure-supported breaths | Two-level (inspiratory/expiratory) pressure |
Backup Ventilation | Yes (preset mandatory rate) | No guaranteed rate | Limited (usually noninvasive) |
Patient Effort Required | Moderate | High (patient determines RR & VT) | Moderate to high (depends on mask seal) |
Weaning Potential | Good (can gradually reduce mandatory rate) | Very good (encourages spontaneous effort) | Generally used for noninvasive or mild cases |
Suitability for Altered Mental Status | Moderate (requires patient triggering for additional breaths) | Good if patient can trigger consistently | Less optimal if severe alteration or tracheostomy needed |
Key Advantages | Guarantees a minimum ventilation | Excellent synchrony & comfort, easier weaning | Noninvasive option for less severe cases |
Key Limitations | Possible dyssynchrony if sedation is off | No mandatory minimum ventilation | Not suitable for high apnea risk or severe consciousness depression |
Why PSV for This Patient?
Guardian consent obtained for IRB-approved clinical research aimed at disseminating better clinical practices in hemodynamics.
Written on March 28, 2025
A 47-year-old woman with metastatic cerebral carcinoma developed marked tachypnoea (43–48 breaths min⁻¹) and apparent ventilator asynchrony after an episode of regurgitation while receiving pressure-controlled ventilation. This report summarises the clinical findings, analyses the potential mechanisms of patient–ventilator dyssynchrony, and proposes a structured, evidence-based management algorithm. The discussion emphasises protective ventilation, airway protection, neurocritical-care goals, and the importance of waveform analysis.
Variable | Observed value | Usual target / reference | Comment |
---|---|---|---|
Age / sex | 47 y, female | – | Glioblastoma with extracranial metastasis |
Cancer stage | IV (cerebral) | – | Palliative intent |
Airway | Cuffed ETT, ↓gag reflex post-regurgitation | Secured, cuff pressure 20–30 cmH₂O | High aspiration risk |
Core temperature | 37.7 °C | 36–37.5 °C | Mild pyrexia |
Set ventilator mode | P-control + pressure support | Mode choice dependent on lung mechanics | Hybrid settings |
Set P_control | 8 cmH₂O | 12–18 cmH₂O (ARDSnet low-VT) | Likely insufficient |
Set pressure support | 8 cmH₂O | 8–12 cmH₂O | Acceptable |
Set respiratory rate | 20 min⁻¹ | 16–20 min⁻¹ | Protective target |
Measured RR | 43–48 min⁻¹ | 16–24 min⁻¹ | Severe tachypnoea |
SpO₂ | (not provided) | ≥ 94 % (brain injury) | Must be confirmed |
PaCO₂ (ABG) | (awaiting) | 35–45 mm Hg | Needed to guide ICP |
The bar chart below illustrates the disparity between the programmed and observed respiratory rates, highlighting probable trigger asynchrony.
Step | Action | Rationale |
---|---|---|
1 | Increase inspiratory pressure (P_control) by 2–4 cmH₂O increments, targeting Vᴛ 6 ml kg⁻¹ IBW | Reduces respiratory drive, improves alveolar ventilation |
2 | Adjust trigger sensitivity (flow 1–2 L min⁻¹ or pressure –1 cmH₂O) | Minimises ineffective triggering |
3 | Prolong inspiratory time (Tᵢ) or use pressure-controlled assist/control to synchronise cycling | Avoids double-triggering |
4 | Titrate pressure support (8 → 12 cmH₂O) if switching to PSV mode | Off-loads work of breathing |
5 | Optimise sedation-analgesia (e.g., fentanyl + propofol; consider dexmedetomidine for neuro-ICU) | Blunts excessive drive |
6 | If refractory, trial neuromuscular blockade (short-acting) while correcting underlying trigger | Temporarily abolishes dyssynchrony |
7 | Re-evaluate ABG 30 min after each major change; target PaCO₂ 35–40 mm Hg and PaO₂ ≥ 80 mm Hg | Maintains cerebral perfusion pressure |
8 | Initiate aspiration prophylaxis: broad-spectrum antibiotics if infiltrates + sepsis markers | Treats secondary infection |
9 | Implement lung-protective strategy: PEEP titration per driving pressure or FiO₂–PEEP tables | Prevents VILI |
10 | Escalate to volume-controlled ventilation or closed-loop mode (e.g., iVAPS) if control remains poor | Provides consistent Vᴛ |
Trigger type | Recommended range | Typical setting |
---|---|---|
Flow trigger | 1–3 L/min | 2 L/min |
Pressure trigger | –0.5 to –2 cmH₂O | –1 cmH₂O |
Ventilator mode | Absolute Tᵢ | I:E ratio |
---|---|---|
Volume-controlled | 0.8–1.2 s | 1:2 to 1:3 (≈25–33%) |
Pressure-controlled | 0.8–1.0 s | Ti% ≈ 30–35% |
Setting | Adjustment | Purpose |
---|---|---|
Trigger sensitivity |
Lower threshold (↑ sensitivity)
|
|
Inspiratory time | Maintain within above ranges; adjust Ti% based on drive and mechanics |
|
|<--- Insp. (30%) --->|<------ Exp. (70%) ------>|
Note: Excessive sensitivity may lead to auto-triggering (e.g., from circuit noise or cardiac oscillations). Fine adjustments guided by waveform inspection are advised.
Protective ventilation in brain-injured oncology patients requires a balance between minimising ventilator-induced lung injury and avoiding secondary cerebral insults. Hypoxaemia and hypercapnia both augment cerebral blood flow and raise ICP; conversely, excessive hyperventilation may cause cerebral vasoconstriction and ischaemia. The observed tachypnoea likely reflects inadequate tidal volume delivery and a strong central drive, compounded by agitation and airway irritation after regurgitation.
Pressure control of 8 cmH₂O typically yields Vᴛ < 4 ml kg⁻¹ in most adults, insufficient for CO₂ clearance. Gradual increments, combined with careful waveform analysis, improve synchrony without abrupt ICP shifts. Sedation using agents with minimal ICP impact (propofol, dexmedetomidine) helps dampen excessive respiratory drive. Neuromuscular blocking agents should remain a rescue strategy given deleterious effects on neurological assessment.
Empirical antibiotics are justified when aspiration is likely and temperature rises; however, fever alone (37.7 °C) warrants cultures before escalation. Early bronchoscopy clears obstructive debris, reducing ventilator demands.
This manuscript has been proof-read and formatted for clarity. Figures and tables are included to aid comprehension.
Guardian consent obtained for IRB-approved clinical research aimed at disseminating better clinical practices in hemodynamics.
Written on May 1, 2025
An elderly woman without significant premorbid conditions aspirated food, developed aspiration pneumonia, and was transferred after initial management at another hospital.
2025-05-08 intubation, sedation (midazolam + remifentanil) → plan tapering if ABGA okay
target tidal volume: 250 – 350
Vent PS mode
2025-05-09 if vital signs maintain well overnight, reduce sedation, check CT and decide extubation timing. Extubation done. If saturation maintained well over the weekend, plan ward transfer
Continuous infusions of midazolam (benzodiazepine) and remifentanil (ultra-short-acting opioid) are titrated to a sedation goal (e.g., Richmond Agitation-Sedation Scale, RASS −2 to −3). At such depths many patients maintain a degree of respiratory drive, allowing patient-triggered breaths even while intubated.
Pressure-Support Ventilation augments each patient-initiated inspiration with a preset pressure. If the patient’s respiratory drive is preserved (albeit dampened), PS mode:
In PS mode clinicians do not prescribe an absolute VT; instead, the delivered volume is the result of:
The note “250–350 mL” therefore represents an anticipated safe range (≈ 6 mL kg−1 predicted body weight) used to titrate support, not a ventilator-enforced target.
Mode | Typical initial use | Set VT? | Spontaneous breaths allowed? |
---|---|---|---|
Volume-Controlled (VC)-AC | Severe respiratory failure, deep sedation or paralysis | Yes | No (backup mandatory) |
Volume SIMV + PS | Transition phase; partial support | Yes (mandatory breaths) | Yes |
Pressure-Controlled (PC)-AC | Poor compliance (e.g., ARDS) | No (volume varies) | No (unless additional PS window) |
Pressure-Support (PS) | Spontaneous breathing with reduced work | No | Yes (all breaths) |
CPAP ± PS | Final weaning step before extubation | No | Yes |
⚙️ Interpretation: PS mode on 5-08 indicates the sedation level permitted spontaneous efforts. The documented “sedation reduction” on 5-09 likely refers to further tapering to reach minimal or no sedation before extubation. The ventilator was probably left in PS (or switched to CPAP with minimal PS) as the patient awakened, because these modes seamlessly accommodate returning respiratory drive without risking excessive mandatory volumes.
Disclaimer ⚠️ The following dosage ranges and preparation methods are based on widely used ICU references (e.g., PADIS 2018, ESPEN 2022).
Sedation target (RASS) |
Midazolam loading ± bolus |
Midazolam continuous rate |
Remifentanil loading ± bolus |
Remifentanil continuous rate |
Typical final mix (→ infusion concentration) |
Clinical cues of excessive depth 🛑 |
---|---|---|---|---|---|---|
Light −1 to 0 |
None or 0.01 mg kg⁻¹ (slow IV) |
0.02–0.05 mg kg⁻¹ h⁻¹ | None or 0.5 µg kg⁻¹ (over 1 min) |
0.02–0.05 µg kg⁻¹ min⁻¹ |
Midazolam 50 mg + 50 mL NS → 1 mg mL⁻¹ Remifentanil 2 mg + 50 mL NS → 40 µg mL⁻¹ |
RASS ≤ −3, RR < 8 min⁻¹, ETCO₂ ↑ |
Moderate −2 to −3 |
0.02 mg kg⁻¹ | 0.05–0.1 mg kg⁻¹ h⁻¹ | 1 µg kg⁻¹ | 0.05–0.1 µg kg⁻¹ min⁻¹ |
Midazolam 40 mg + 80 mL D5W → 0.5 mg mL⁻¹ Remifentanil 4 mg + 50 mL NS → 80 µg mL⁻¹ |
Loss of pattern-triggered breaths, PaCO₂ > 55 mmHg |
Deep −4 to −5 |
0.03–0.05 mg kg⁻¹ | 0.1–0.2 mg kg⁻¹ h⁻¹ (rarely > 0.15 mg kg⁻¹ h⁻¹ in elderly) |
1–2 µg kg⁻¹ | 0.1–0.2 µg kg⁻¹ min⁻¹ |
Midazolam 100 mg + 50 mL NS → 2 mg mL⁻¹ Remifentanil 5 mg + 100 mL NS → 50 µg mL⁻¹ |
Apnea > 20 s, absent cough, pH < 7.25 |
Midazolam 1 mg mL⁻¹, protect from light
”.Midazolam pump rate (mL h⁻¹) = (Target mg kg⁻¹ h⁻¹) × Patient kg ÷ Concentration (mg mL⁻¹)
Remifentanil pump rate (mL h⁻¹) = (Target µg kg⁻¹ min⁻¹) × Patient kg × 60 ÷ Concentration (µg mL⁻¹)
In elderly or frail adults, apnea becomes likely when any of the following thresholds are exceeded for > 10 min:
Guardian consent obtained for IRB-approved clinical research aimed at disseminating better clinical practices in hemodynamics.
Written on May 21, 2025
Condition |
C
dyn
(mL cm −1 H 2 O) |
Airway resistance
(cm H 2 O L −1 s) |
Breath timing
(s) |
TC
(s) |
3 TC
(s) |
WOB
(J L −1 ) |
|||
---|---|---|---|---|---|---|---|---|---|
Ri | Re | T i | T e | Elastic (WOB v ) | Resistive (WOB p ) | ||||
Normal | 50 – 100 | 0.5 – 2.0 | 0.5 – 3.0 | 0.8 – 1.2 | 1.6 – 2.4 (I:E≈1:2) | 0.10 – 0.20 | 0.30 – 0.60 | 0.20 – 0.25 | 0.10 – 0.15 |
Atelectasis | 20 – 40 | 1 – 3 | 1 – 3 | 0.8 – 1.0 (↑RR) | 1.2 – 1.5 (I:E≈1:1.5) | 0.05 – 0.12 (low C) | 0.15 – 0.36 | 0.35 – 0.50 (elastic-dominant) | 0.15 – 0.20 |
COPD / Asthma | 70 – 120 | 5 – 10 | 10 – 30 | 0.8 – 1.0 | 3.0 – 5.0 (I:E ≥ 1:4) | 0.30 – 0.50 | 0.90 – 1.50 | 0.30 – 0.40 | 0.50 – 0.90 (resistive-dominant) |
Pneumonia | 30 – 50 (variable) | 2 – 5 | 2 – 5 | 0.9 | 1.8 (I:E≈1:2) | 0.10 – 0.20 | 0.30 – 0.60 | 0.40 – 0.60 | 0.15 – 0.25 |
Severe ARDS | 15 – 30 | 5 – 10 | 5 – 15 | 1.0 – 1.5 (I:E≈1:1) | 1.0 – 1.5 | 0.05 – 0.15 | 0.15 – 0.45 | 0.60 – 0.90 (elastic-dominant) | 0.30 – 0.60 |
Preset | Cdyn (mL cm−1 H2O) |
Ri (cm H2O L−1 s) |
Re (cm H2O L−1 s) |
Implementation notes |
---|---|---|---|---|
Normal baseline | ≈ 70 | ≈ 1.0 | ≈ 2.0 | Reference values for healthy adult mechanics. |
Atelectasis module | ≈ 30 | ≈ 3 | ≈ 3 | Shorten time constants to model rapid emptying. |
COPD moderate module | ≈ 90 | ≈ 6 | ≈ 15 | Extend Te to prevent gas-trapping. |
Asthma acute module | ≈ 80 | ≈ 8 | ≈ 25 | Allow transient peaks in expiratory resistance. |
Pneumonia module | ≈ 45 | ≈ 4 | ≈ 4 | Moderate rise in both resistive and elastic loads. |
Severe ARDS module | ≈ 20 | ≈ 8 | ≈ 8 | Pair with inverse I:E or prone-position simulation options. |
For dynamic simulations, compute the time constant (τ) in real time as τ = (Ri + Re / 2) × C dyn ; three time constants (≈ 95 % equilibration) mark the end of filling or emptying. Incorporating separate elastic and resistive work components allows visualisation of disease-specific energy demands. Finally, ensure breath-to-breath variability for stochastic realism, particularly in asthma and ARDS presets.
Written on June 9, 2025
In developing the nGeneHemodynamicSimulation_VentilatorTestLung and its interaction with the Ventilator, the choice of integrating both the Strategy and Observer design patterns is driven by the need for dynamic behavior adjustment and robust state monitoring within our simulation system. These patterns are selected to enhance the flexibility, maintainability, and operational efficiency of our hemodynamic simulation platform.
High Flow Nasal Cannula (HFNC) therapy is increasingly recognized in modern respiratory care for its ability to deliver heated and humidified medical gas at high flows through a nasal cannula. This advanced respiratory support technique offers significant improvements over traditional low-flow systems (LFNC), which typically provide only up to 6 liters per minute, achieving maximum FiO2 levels of around 0.37 to 0.45. Although systems such as the 8-10L oxygen reservoir mask can deliver FiO2 levels of up to 80% or more, HFNC is preferred for its capability to provide up to 100% humidified and heated oxygen at flow rates reaching 60 liters per minute. This feature ensures a stable fraction of inspired oxygen (FiO2), even amid changing patient demands or respiratory patterns, effectively addressing a key limitation of traditional oxygen therapy methods like wall oxygen with a reservoir mask, which cannot guarantee stable FiO2 during flow changes.
HFNC significantly enhances oxygenation and ventilation by delivering air at rates that exceed a patient's physiological capacity, effectively addressing the limitations posed by physiological dead space. Typically, dead space accounts for about one-third of the tidal volume, leading to CO2 accumulation and decreased availability of oxygen for diffusion. HFNC uses high flow rates to displace stagnant CO2 with fresh O2, increasing the partial pressure of oxygen (PAO2) and creating a more favorable oxygen diffusion gradient. This mechanism is particularly beneficial for enhancing CO2 clearance and alleviating symptoms of dyspnea, thereby increasing minute ventilation and effectively reducing dead space. These benefits are especially advantageous for patients with chronic obstructive pulmonary disease (COPD), as HFNC therapy eases their work of breathing and improves overall respiratory efficiency.
Additionally, HFNC reduces nasopharyngeal airway resistance by applying positive pressure that dilates the airways. According to the Hagen-Poiseuille law, airway resistance is inversely proportional to the fourth power of the airway radius (R = 8 n l / π r4), meaning that increasing the radius decreases resistance and enhances airflow. This physiological advantage is pivotal in managing respiratory conditions that involve compromised airway dynamics or ineffective air exchange, making HFNC an essential tool in respiratory care. The clinical benefits of HFNC are particularly evident in conditions like acute hypoxemic respiratory failure and COPD exacerbations, where the reduction in airway resistance can improve gas exchange and reduce the work of breathing. In acute settings, the positive airway pressure provided by HFNC helps maintain alveolar stability, enhancing oxygenation and comfort, which is crucial for patient outcomes. Studies such as the FLORALI trial highlight HFNC's role in reducing mortality and increasing ventilator-free days compared to conventional oxygen therapies. Additionally, HFNC's consistent oxygen delivery makes it highly effective for patients during critical pre and post-extubation periods, ensuring optimal respiratory support.
Moreover, the humidification and heating provided by HFNC reduce dryness in the nasal passages and mouth, minimizing gastrointestinal disturbances and the risk of atelectasis by maintaining mucociliary function and airway patency. HFNC's effectiveness extends to neonatal care, providing gentle and appropriate respiratory support for the delicate nature of neonatal airways. This is facilitated by adjustable flow rates from systems like the widely used Airvo, OmniOx and MC FLO HFNC devices, which offer settings ranging from 10 to 60 L/min for adults and 15 to 30 L/min for pediatrics, managed by controlling the flow meter connected to wall oxygen.
However, HFNC is not without potential drawbacks. It can lead to excessive CO2 reduction, potentially suppressing the respiratory drive if not carefully monitored. The therapy may also increase expiratory resistance, leading to an inadvertent continuous positive airway pressure (CPAP) effect that could elevate airway pressures and result in complications such as barotrauma, volutrauma, and pneumothorax. Additionally, the possibility of patients adjusting or removing the nasal cannula can create stability issues and compromise the delivery of precise FiO2. In scenarios of severe respiratory failure where higher levels of support are necessary, traditional mechanical ventilation may be required. This includes situations necessitating intubation and invasive ventilation to manage higher pressures safely and effectively, highlighting HFNC's limitations in more critical care scenarios.
• An 80-year-old man with a history of descending-colon carcinoma (resected 2021, adjuvant chemotherapy completed)
• Newly diagnosed non-small-cell lung cancer, adenocarcinoma, left-upper-lobe, cT2N3M1b, stage IV
• Patient declined further oncologic therapy and is receiving comfort-oriented care
• Current oxygen delivery in the ward listed as “FiO2 30 %, Flow 40 L/min”, yet nursing record shows 30 L/min, suggesting mis-entry of flow rate
Parameter | Typical adult range | Clinical purpose |
---|---|---|
FiO2 (fraction of inspired O2) | 0.21 – 1.00 | Adjusts oxygen concentration to reach target SpO2 |
Flow (total gas flow rate) | 40 – 60 L · min-1 | Meets or exceeds peak inspiratory demand; generates low-level PEEP (≈3–5 cm H2O) |
Temperature | 31 – 37 ℃ | Humidifies gas, prevents airway dryness, improves secretion clearance |
Feature | HFNC | Simple / Non-rebreather mask |
---|---|---|
Precise FiO2 delivery | ✓ Closed-loop blender gives exact 21 – 100 % | ✗ Variable (entrains room air with each breath) |
Flow matching peak demand | ✓ 40–60 L · min-1 meets inspiratory flow | ✗ Limited to ≈ 15 L · min-1 |
Dead-space washout | ✓ Continuous high flow flushes CO2 | ✗ Minimal effect |
Low-level PEEP | ✓ 3–5 cm H2O improves oxygenation | ✗ None |
Comfort & communication | ✓ Small nasal prongs allow talking, eating | ✗ Mask hinders oral intake, speech |
Humidification | ✓ Heated, 100 % relative humidity | ✗ Dry gas irritates mucosa |
Patient: __________________ (Room ___) Date/Time: __________ Order by: Dr _____________________1. Initiate heated, humidified high-flow nasal cannula oxygen therapy • Flow: 40 L · min-1 • FiO₂: 0.30 (30 %) 2. Target SpO₂: 92 – 96 %★Apply HFNC: 40 L/min@FiO2 0.30; keep SpO2>= 92 %
3. Titration protocol • If SpO₂ < 92 % for > 2 min → increase FiO₂ by 0.05 (max 0.60) • If FiO₂ ≥ 0.60 and SpO₂ < 92 % or rising PaCO₂, notify physician • When SpO₂ > 96 % for > 10 min → decrease FiO₂ by 0.05, maintain flow ≥ 40 L · min-14. Monitoring • Continuous pulse oximetry • Record RR, HR, work of breathing hourly • ABG as clinically indicated 5. Nursing documentation • Chart actual flow & FiO₂ hourly and after each adjustment • Note patient comfort and adverse events 6. Weaning criteria • Consider step-down to nasal cannula ≤ 5 L · min-1 when stable for ≥ 4 h on FiO₂ ≤ 0.30 and flow 30 L · min-1
Guardian consent obtained for IRB-approved clinical research aimed at disseminating better clinical practices in hemodynamics.
Written on June 3, 2025
The ventilator continuously tracks elapsed time since the last mandatory inflation. If a patient effort occurs within ≤ 60 % of the predetermined cycle time (or ≤ 10 s, whichever is shorter), the machine “synchronizes” and converts that effort into the next mandatory breath. Beyond this window, any patient‑initiated effort is treated as a separate spontaneous breath.
Set RR (bpm) ≡ SIMV rate |
Cycle period (s) 60 ÷ RR |
Sync-window ≤ 60 % of period (patient effort → mandatory) |
---|---|---|
14 | 4.3 | ≤ 2.6 |
12 | 5.0 | ≤ 3.0 |
10 | 6.0 | ≤ 3.6 |
8 | 7.5 | ≤ 4.5 |
6 (weaning) | 10.0 | ≤ 6.0 |
4 (late-wean) | 15.0 | ≤ 9.0 |
Practical weaning pattern used on most adult units: once the patient
meets readiness criteria, clinicians commonly lower the mandatory SIMV rate in 2-bpm
steps (e.g. 14 → 12 → 10 → 8 → 6 → 4 → 2 bpm).
• Pacing: up to three reductions per day, spaced ≈ 3 h apart, or slower if gas-exchange,
work-of-breathing, or hemodynamics wobble.
• Targets: maintain VT ≈ 6 mL·kg⁻¹ IBW and SpO₂ > 92 %; draw ABGs when clinical status
changes.
• Transition: at ≤ 4 bpm (or when ≥ 80 % of breaths are spontaneous and pressure-supported) many centres
switch to pure PS/CPAP and begin daily 30-min spontaneous-breathing trials.
• Abort criteria: RR > 35, SpO₂ < 90 %, pH < 7.30, HR > 140 bpm, or marked distress.
PEEP 10 cmH2O P control 7 cmH2O → Mandatory peak 17 cmH2O PS 5 cmH2O → Spontaneous peak 15 cmH2O RR 10 bpm (6 s period)
SIMV rate
1–60 breaths min-1.Breath-cycle time
, \(T_{\text{cycle}}\) 0.5–15 s (infant) or 1–15 s (adult).Mandatory back-up breaths protect against periods of apnea. Excessive mandatory rates may blunt intrinsic drive, whereas rates set too low risk hypoventilation if spontaneous effort diminishes. Continuous monitoring of tidal volume, minute ventilation, end-tidal CO2 and patient comfort is essential on both ResMed and SERVO platforms.
Written on June 9, 2025
Quick take: Both P(A)CV and P(A)C are pressure-controlled assist-control modes that can be patient-triggered or time-triggered.
Their differences hinge on two main points:
1) The circuit type in use (valve/double-limb vs leak/single-limb), which changes the mode name and pressure terminology on the interface.
2) Whether the Safety Vt volume-guarantee feature is enabled. With Safety Vt active in either mode, the ventilator automatically adjusts inspiratory pressure (up to 2 cmH 2 O per breath, within a user-set ceiling) to achieve the target tidal volume—functionally the same concept as PRVC (pressure-regulated volume control).
ResMed Astral ventilators support two distinct patient circuit configurations: a valve (double-limb) circuit and a leak (single-limb) circuit . The choice of circuit influences how the ventilator labels its modes and pressure settings, even though the underlying breath delivery mechanics remain the same. In essence, switching between a double-limb and single-limb circuit does not change how breaths are controlled; it simply changes the terminology and measurement capabilities.
Notably, the ventilator’s mode menu is partitioned by circuit type: when a double-limb valve circuit is selected in the settings, modes like P(A)CV become available; when a single-limb leak circuit is selected, modes like P(A)C appear instead. The underlying control scheme is equivalent— an operator can think of IPAP on a leak circuit as being analogous to P control + PEEP on a valve circuit —but the device uses the appropriate terms and mode names to match conventional usage in each setting.
Circuit type | Mode name shown | Pressure control labels |
---|---|---|
Valve / double-limb | P(A)CV | P control & PEEP |
Leak / single-limb | P(A)C | IPAP & EPAP |
The differences between single and double-limb operation are partly hardware and partly software. A double-limb circuit requires a ventilator with two separate ports (inspiratory and expiratory) and an exhalation valve mechanism. For example, the ResMed Astral 150 model can accommodate a detachable double-limb circuit adapter (providing the second port and valve), whereas the Astral 100 model has only a single port and therefore cannot support a true double-limb configuration. If a ventilator lacks the physical second port or valve, it is limited to single-limb modes. Conversely, even on a device with dual ports, the firmware must be capable of a "leak circuit" mode (with appropriate leak compensation and trigger algorithms) to safely use a single-limb setup. When the circuit type is changed on a capable device, the ventilator software adjusts its mode options and alarm algorithms accordingly. In Astral devices, a circuit change prompt will initiate a “Learn Circuit” calibration to account for the new circuit’s resistance and compliance.
Identifying the circuit type: In clinical practice, a double-limb circuit is easily recognized by its two hoses joining at a Y-piece (with an exhalation valve module on the expiratory limb), while a single-limb circuit has only one hose (and typically a vented mask or leak port for exhalation). The Astral’s user interface provides cues as well: if the screen displays settings like “P control” and “PEEP” (and shows measured exhaled tidal volumes), a double-limb circuit is in use; if it displays “IPAP” and “EPAP” and omits exhaled volume readouts, a single-limb circuit is in use. The device’s setup menu also explicitly indicates which circuit type is active, and different alarm messages tend to appear for each (e.g., valve disconnect alarms with double-limb, or high leak warnings with single-limb).
Circuit type | Physical setup | Pressure labels | Key strengths | Limitations |
---|---|---|---|---|
Valve (double-limb) | Two limbs (inspiratory & expiratory) with an active exhalation valve | P control / PEEP |
- Accurate monitoring of exhaled volumes
- Less sensitivity to mask or circuit leaks - Enables advanced monitoring (e.g., capnography) |
- Bulkier equipment with two hoses
- Requires water traps/maintenance for two limbs - Exhalation valve adds cost and complexity |
Leak (single-limb) | One limb with intentional leak port or vented mask | IPAP / EPAP |
- Lighter and simpler setup, ideal for NIV and transport
- Quick to set up and fewer connections - Lower internal volume can improve pressure delivery dynamics |
- Cannot directly measure exhaled tidal volume (estimates only)
- Vulnerable to unintentional leaks affecting ventilation - Risk of CO 2 rebreathing if the leak port is inadequate |
Because of these hardware differences, certain ventilation modes are available only with one circuit type or the other on the Astral (and similar ResMed devices). The table below outlines which modes can be selected with each circuit:
Circuit | Assist/Control modes | Spontaneous/Support modes | Specialty modes |
---|---|---|---|
Valve / double-limb |
Volume Control (VC or ACV)
Pressure Control (P(A)CV) |
Pressure Support (PS) |
SIMV (volume or pressure) with PS
Sigh (periodic hyperinflation) Manual breath |
Leak / single-limb |
Spontaneous/Timed (S/T)
Pressure Control (P(A)C) |
Pressure Support (PS) & PS with Safety V t (PS/SV t ) | Intelligent Volume-Assured PS (iVAPS ± AutoEPAP) |
In summary, the valve circuit option (available on Astral 150) enables traditional ICU modes like SIMV and precise volume-controlled ventilation, whereas the leak circuit option (common to Astral 100/150 and home devices) provides a simpler set of modes tailored to noninvasive support (including unique modes like iVAPS). Importantly, all of these modes, whether in valve or leak configuration, share the same core ventilation principles—differences lie in the interface labels and certain advanced features rather than the fundamental breath delivery.
P(A)CV (Pressure Assist-Control Ventilation) and P(A)C (Pressure Assist-Control) are essentially the same type of ventilatory mode delivered via different circuit setups. Both are pressure-targeted, time-cycled modes in which every breath is delivered to a set inspiratory pressure for a set inspiratory time. They can function as assist-control modes: breaths will be delivered at a minimum set rate, but the patient can trigger additional breaths above the set rate (each triggered breath still receives the full preset pressure and duration). If the patient makes no effort, the ventilator will deliver breaths at the set rate—hence these modes provide full ventilatory support.
When using a double-limb circuit, this mode is labeled P(A)CV on the screen, and the settings will include a P control level above PEEP. With a single-limb circuit, the same mode appears as P(A)C, and the equivalent settings are an IPAP level and an EPAP baseline. In practice, these represent the same pressure targets: for example, an IPAP of 18 cmH 2 O and EPAP of 8 cmH 2 O on a single-limb setup correspond to PEEP = 8 and P control = 10 on a double-limb (since 8 + 10 = 18 total cmH 2 O of inspiratory pressure). The ventilator’s control system ensures that the delivered pressure waveform is the same; only the nomenclature differs. In fact, the Astral device will automatically convert stored settings between IPAP/EPAP and P control/PEEP if the circuit type setting is changed, so that the actual delivered pressures remain consistent.
Shared mechanics: In both P(A)CV and P(A)C modes, inspiration is strictly time-cycled (i.e. the inspiratory phase lasts for a preset inspiratory time on each breath). The patient can initiate (trigger) breaths in either mode if they generate sufficient inspiratory effort, but they cannot terminate the breath early—each breath will continue until the set inspiratory time has elapsed (unlike a purely spontaneous breath in Pressure Support where the patient can cycle to exhalation). The adjustable parameters are identical: respiratory rate, inspiratory time (or I:E ratio), rise time (pressure slope), and trigger/cycle sensitivity thresholds are all available and function the same way in both modes. Neither P(A)CV nor P(A)C provides additional pressure “support” beyond the set pressure target; they are full mandatory breaths, simply allowing the patient to initiate them as needed. This means P(A)C is not a partially spontaneous mode—it is as much a mandatory breath mode as P(A)CV, just presented in the context of a leak circuit.
ResMed’s Astral ventilators offer an optional volume-guarantee feature called Safety V t . This feature can be enabled in several modes (including P(A)CV, P(A)C, S/T, and PS) to ensure a minimum tidal volume is delivered. When Safety V t is active, the ventilator monitors the exhaled (or delivered) tidal volume each breath and compares it to a target set by the clinician. If the volume falls below the target, the ventilator will automatically increase the inspiratory pressure on the next breath (up to a limit of +2 cmH 2 O per breath) until the target volume is achieved or a maximum pressure limit is reached. Similarly, if volumes are exceeding the target, it can decrement the pressure in small steps. The clinician sets an upper pressure cap ( P control max on a valve circuit, or IPAP max on a leak circuit) to restrict how high the pressure may rise. This closed-loop algorithm effectively converts the pressure-control mode into a pressure-regulated volume control mode: the ventilator adjusts pressure as needed to hit the volume goal while otherwise delivering pressure-controlled breaths. In other ventilator brands, analogous modes go by names like PRVC (Pressure-Regulated Volume Control), Autoflow, or PC-VG (Pressure Control - Volume Guaranteed). With Safety V t enabled, P(A)CV and P(A)C perform equivalently to those modes. The Astral display will typically indicate when Safety V t is on (for instance, by showing a blue shield icon or appending “SV” to the mode label), signaling that a volume guarantee is in effect.
Because of the circuit-dependent labeling, the same physical setting may be named differently between P(A)CV and P(A)C. The following table maps the key parameters and limits in a pressure-control breath between the two circuit types, and explains the naming rationale:
Parameter | In P(A)CV (valve circuit) | In P(A)C (leak circuit) | Remarks |
---|---|---|---|
Inspiratory pressure target | P control | IPAP | Same functional meaning (pressure above baseline); label differs by convention |
Baseline pressure (PEEP/CPAP) | PEEP | EPAP | Same level of expiratory positive pressure; “EPAP” term used in NIV context |
Volume guarantee target | Safety V t (mL) (identical term in both modes when enabled) | Tidal volume goal for closed-loop control | |
Upper pressure limit (when Safety V t enabled) | P control max | IPAP max | Maximum pressure the ventilator will deliver (ceiling for the volume guarantee algorithm) |
In practical terms, IPAP = PEEP + P control when comparing these modes, and EPAP = PEEP . All alarm settings and monitoring readouts are based on absolute pressure values (for example, peak inspiratory pressure), so they remain consistent regardless of whether one is looking at a valve or leak circuit display. Clinicians can translate orders between the two terminologies by simple addition or subtraction. For instance, an order to provide “IPAP 20 cmH 2 O / EPAP 5 cmH 2 O” on a leak-circuit device would be implemented as PEEP = 5 with P control = 15 on a double-limb ventilator. Conversely, a setting of PEEP 5 and P control 12 cmH 2 O on a dual-limb ventilator corresponds to EPAP 5 and IPAP 17 on a leak-circuit machine. The Astral will perform these conversions automatically if the circuit type selection is changed, carrying over the intended pressures appropriately.
Note on mode names: The “(A)” in P(A)CV or P(A)C indicates that the mode is assist-capable. If patient triggering is turned off (or not detected), the Astral will simply display the mode as PCV or PC (dropping the “A”). Thus, P(A)C with no spontaneous triggering becomes a pure timed Pressure Control mode. Likewise, when the Safety V t feature is active, the Astral may add a suffix like “/SV” (or show an icon) to denote the active volume guarantee. These nomenclature cues help the user quickly identify whether a patient’s breaths are assisted and whether a volume guarantee is in place.
The following are scenarios illustrating how one might choose between a leak vs valve circuit and utilize the corresponding mode:
Different ventilator manufacturers often use distinct names for modes that are functionally similar. Understanding the terminology differences is important when comparing protocols or translating settings from one machine to another. Below is a comparison of mode naming conventions among three systems: the Maquet Servo series, the ResMed Astral, and the MEK HFT700 (a non-invasive ventilator). The modes are organized from full mandatory support to spontaneous support to highlight their equivalence.
Generic Mode | Maquet Servo-i/u | ResMed Astral 100/150 | MEK HFT700 |
---|---|---|---|
Volume Control (VC) | Volume Control (VC) | (A)CV (Volume Assist/Control) | N/A (no true VC mode) |
Pressure Control (PC) | Pressure Control (PC) | P(A)CV (Pressure AC – displays “PC” if unassisted) | N/A (primarily NIV modes only) |
Bilevel Spontaneous (PSV) | Pressure Support (PS) | PS or PS/SV t (Pressure Support & optionally Safety Vt) | Bi-level S (Spontaneous) |
Bilevel with backup (S/T) | – | (S)T (Spontaneous/Timed, backup rate & optional SV) | Bi-level S/T (via settings) |
Full Bi-level control (Timed) | – | P(A)C (Timed PC on leak circuit) | Bi-level T (Timed mode) |
SIMV (Volume-targeted) | SIMV (VC+PS or PRVC+PS) | V-SIMV | N/A |
SIMV (Pressure-targeted) | SIMV (PC+PS) | P-SIMV | N/A |
Bi-level Open Lung/APRV | Bi-Vent / APRV | N/A (not available on Astral) | N/A |
CPAP/EPAP only | CPAP (with or without PS) | CPAP | CPAP |
High-flow oxygen | High Flow (optional mode) | N/A | HF (High Flow) |
Notes: In the Astral column, parentheses around a letter (e.g., (A) or (S)) indicate that the letter will appear when the function is active. For example, Astral displays “(A)CV” when patient triggering is available; if the patient trigger is turned off, it would simply display “CV” for a volume-controlled mode or “PC” for a pressure-controlled mode. Similarly, “(S)T” indicates a spontaneous/timed mode; when the patient is breathing above the set rate, breaths are spontaneous (S), but if they do not, the machine delivers timed (T) backup breaths. Astral appends “SV” or “SVt” to modes like (S)T or PS to denote the Safety Volume guarantee is enabled on those modes (providing a volume-assured pressure support).
When converting ventilation orders or protocols between different ventilator brands, it is crucial to match the intended clinical strategy rather than relying on mode names alone. Pay attention to suffixes or special mode designations, as they often signify important features like patient-trigger availability or volume guarantees.
Many noninvasive ventilators classify their bi-level modes using the letters S, T, and S/T, which correspond to how breaths are triggered and cycled:
In some devices, an additional designation is used for volume-assured pressure support. For example, one might see “S/T (AVAPS)” on a Philips ventilator or “S/V” on another device, indicating that while the mode is fundamentally Spontaneous/Timed, the ventilator will automatically adjust the IPAP level to maintain a target tidal volume (this is often termed Average Volume Assured Pressure Support). ResMed’s implementation of a volume-assured pressure support is the Safety V t feature, which can be added to its S/T mode (displayed as “(S)T / SV”) or to pure PS mode (“PS/SV t ”). Regardless of naming, these modes still follow the same principles: S mode breaths when the patient triggers, T mode backup if they do not, and an optional algorithm to tweak pressure for volume targets.
Written on July 10, 2025
Note: The exact naming conventions and parameter options may vary by device or manufacturer. While these settings typically apply to ResMed devices that offer an (A)C or Volume Control mode, be sure to verify with the official device manual or manufacturer guidelines to confirm the specific parameters available on a particular model.
Modern non-invasive ventilation (NIV) progressed from early nasal CPAP in the 1980s to bi-level positive airway pressure (BiPAP) in the 1990s and to HFNC + NIV hybrids in the 2010s. The OmniOx HFT700 embodies this trajectory by integrating HFNC, CPAP, and bi-level modes in one turbine-driven, fully humidified platform.
The OmniOx HFT700 unifies high-flow nasal cannula (HFNC), CPAP, and advanced bi-level ventilation within a versatile platform. Mastery of key parameters such as IPAP (PIP), EPAP (PEEP), trigger modes, trigger sensitivity, Ti, and rise time allows clinicians to tailor therapy to patient needs, minimising asynchrony and improving clinical outcomes.
Variable | Common starting point | Usual clinical span |
---|---|---|
Total flow | 30 – 40 L min-1 | 30 – 60 L min-1 (up to 70 L min-1 when demand is very high) |
FiO2 | 0.40 – 0.60 | 0.21 – 1.00 (21 – 100 %) |
Clinical scenario | Recommended starting flow (L min-1) |
---|---|
General adult (no major respiratory comorbidity) | 35 – 40 |
COPD | 25 – 35 |
Cardiogenic pulmonary oedema | 40 – 60 |
Obesity or baseline dyspnoea | Up to 60 |
Community-acquired pneumonia | 30 – 60 |
ARDS | 40 – 70 |
Acute asthma | 30 – 50 |
Rationale: Higher flows improve nasopharyngeal wash-out and generate flow-dependent PEEP (≈ 3–5 cm H2O); however, COPD patients and those at risk of CO2 retention may require initially lower velocities.
Severity markers | Flow target (L min-1) | Why |
---|---|---|
Mild hypoxaemia, RR < 22 | 30 – 35 | Meets inspiratory demand with minimal noise/velocity. |
Moderate distress, RR 22 – 28 | 35 – 50 | Enhances CO2 clearance; accommodates ↑ minute ventilation. |
Severe distress, RR > 28 or hypercapnia | 50 – 60 (+) | Maximises PEEP-like effect and O2 delivery; consider escalation if no improvement. |
Step | Setting | Clinical response |
---|---|---|
Initiation | 25 L min-1 + FiO2 0.35 | SpO2 89 %, RR 26 |
Adjustment | Increase flow to 30 L min-1 | SpO2 ≥ 92 %, RR ≤ 24 |
Stabilisation | Gradually ↓ flow by 5 L min-1 steps | Maintain target saturation & comfort |
Readiness for discontinuation | FiO2 < 0.40 and flow ≤ 20–25 L min-1 | Consider switch to Venturi / low-flow O2 |
Escalate promptly to non-invasive ventilation or invasive airway management.
Tip | Explanation |
---|---|
Humidification: | Always run a heated humidifier; dry gas quickly causes discomfort and mucosal injury. |
Cannula sizing: | Use the largest prong that fills ≤ 2/3 of the nares to minimise leak yet allow purge flow. |
Positioning: | Semi-recumbent ≥ 30° head-up improves diaphragmatic excursion and secretion clearance. |
Monitoring: | Track RR, SpO2, subjective dyspnoea, and transcutaneous/arterial CO2 where available. |
START 30–40 L → Re-assess @10 min
↓
RR >24 or ↑ work? ──► +5–10 L
RR <18 and stable? ─► –5 L (or maintain)
SpO₂ < target? ─────► ↑ FiO₂
SpO₂ > target? ─────► ↓ FiO₂
Stable on FiO₂ <0.40 & Flow <25? ─► Trial off HFNC
The RR detection option activates an internal algorithm that analyses subtle fluctuations in the delivered high-flow gas stream to identify each inspiratory–expiratory cycle. When set to On the ventilator:
When Off, the screen shows “— — —” instead of a numeric RR, and every alarm that depends on RR is automatically suppressed.
Continuous RR surveillance during high-flow nasal cannula (HFNC) therapy is recognised as a sensitive indicator of deteriorating respiratory mechanics or metabolic demand. Because high flows can mask accessory-muscle movement and muffle breath sounds, electronic detection:
The turbine maintains a constant baseline flow (1 – 60 L min-1). Each inspiratory effort causes a transient fall in circuit pressure proportional to inspiratory demand, while expiration produces the opposite deflection. The micro-processor applies a leak-compensated, band-pass filter to these oscillations, then timestamps the mid-points between adjacent peaks to derive the breath-to-breath interval. The inverse of this interval is reported as RR (breaths min-1). Artefacts caused by coughing, talking, or line occlusion are rejected, and calculation is paused if flow is intentionally interrupted for suction.
To minimise nuisance alarms where these limitations outweigh the benefits—or where alternative monitoring is already in place—the manufacturer ships the device with RR detection Off by default, leaving activation to the clinician’s discretion.
Feature | RR detection On | RR detection Off |
---|---|---|
Numeric display (main screen) | 0 – 300 bpm range | “— — —” placeholder |
High / low RR alarms | Enabled (user-set limits) | Disabled |
Apnoea timer | Counts down from last detected breath | Inactive |
Trend storage & export | RR trend plotted and logged | No RR trend recorded |
Remote-monitoring output (HL7 / Wi-Fi) | RR transmitted | Field blank |
• High leak (e.g., ill-fitting nasal prongs) or excessive patient movement can degrade RR signal quality and trigger “Respiration not detected” messages.
• Deliberate mouth-breathing may reduce inspiratory pressure swings below the detection threshold; adjust cannula fit or raise flow if required.
• When SpO2 feedback (TSF) is enabled, RR detection should remain active so that both oxygenation and ventilation indicators are captured synchronously.
• After toggling RR detection, verify alarm volumes and nurse-call connectivity to avoid inadvertent silencing of critical alerts.
RR detection provides a low-burden, high-value safeguard against unnoticed respiratory compromise during HFNC therapy. Nevertheless, potential for false alarms, signal instability, and added data-management duties justify a conservative factory default of Off. When the clinical environment supports reliable signal acquisition and staff are trained to interpret the data, enabling the feature is strongly recommended to preserve full-featured monitoring and alarm functionality.
High-flow oxygen therapy (HFOT) delivers heated, humidified, precisely titrated gas flows that meet or exceed the patient’s spontaneous inspiratory demand. Two principal interfaces are in current clinical use: the high-flow nasal cannula (HFNC) and the high-flow T-piece (HFT, sometimes termed high-flow tracheal oxygen when connected to an artificial airway). Their shared goal is optimized oxygenation with enhanced comfort, yet subtle technical and physiologic distinctions guide interface selection.
A system that provides blended air–oxygen via wide-bore nasal prongs at 20 – 60 L min−1 in adults, with independently titratable FiO2 0.21 – 1.00. Gas is actively warmed to 37 °C and fully saturated (≈ 100 % relative humidity).
A heated-humidified high-flow circuit that connects through a T-shaped adapter to an artificial airway (tracheostomy or endotracheal tube) or, less commonly, to a face mask. Typical adult settings employ 30 – 60 L min−1 flow with the same FiO2 range as HFNC. Flows below 10 L min−1 constitute conventional (non-high-flow) T-piece trials.
Parameter | HFNC | High-flow T-piece | Clinical note |
---|---|---|---|
Initial flow (adult) | 20 – 35 L min−1, escalate to 60 L min−1 | ≥ 30 L min−1, up to 60 L min−1 | Higher flows required in HFT to compensate for open-circuit leak. |
FiO2 range | 0.21 – 1.00 | 0.21 – 1.00 | Both use entrainment blenders or ventilator-integrated mixers. |
Gas conditioning | 37 °C; ~100 % RH | 37 °C; ~100 % RH | Essential for secretion management, especially with bypassed upper airway. |
Positive airway pressure | 2 – 7 cm H2O (flow-dependent) | < 2 cm H2O | Lower with HFT because of the open expiratory limb. |
Dead-space washout | High (nasopharyngeal) | Moderate (tracheal only) | Upper-airway washout is lost once the airway is bypassed. |
Careful flow escalation is advised: flows below 30 L min−1 risk inadequate humidification and secretion crusting, whereas excessive flows may provoke discomfort if temperature control is lost.
Variable | Common starting point | Usual clinical span |
---|---|---|
Pressure | 8 – 10 cm H2O | 4 – 20 cm H2O (mean ≈ 9) |
FiO2 | 0.21 – 0.30 | 0.21 – 1.00 (21 – 100 %) |
Patient profile | Suggested pressure (cm H2O) | Considerations |
---|---|---|
Mild-to-moderate OSA, BMI < 30 kg m-2, AHI < 15 | 5 – 8 | Often adequate; lower starting pressure improves comfort and adherence. |
Severe OSA (AHI > 30) or positional apnoeas | 8 – 12 | Higher baseline pressure reduces event frequency across sleep stages and positions. |
Morbid obesity, significant hypoxaemia, or requirement for high supplemental O2 | 12 – 16 | Addresses elevated closing pressures of pharyngeal airway; confirm tolerance and leak control. |
Persistent residual events on auto-CPAP (95th percentile pressure > 15 cm H2O) | 15 – 20 | Fixed high-pressure trial or bi-level conversion may be needed; monitor for aerophagia. |
Select pressure via in-lab titration or validated auto-titration, aiming to abolish apnoea–hypopnoea events and normalise oxygen saturation. Increase FiO2 only if residual desaturation persists after optimal pressure is confirmed. Re-evaluate after significant weight change, surgical intervention, or continued residual events on download reports. Review adherence, residual index, and patient comfort at each follow-up to guide further optimisation.
In CPAP mode the HFT700 delivers a constant baseline pressure (4 – 20 cmH2O). Pressure Assist + (PA+) and Pressure Assist - (PA-) are small, patient-triggered pressure pulses that momentarily augment or relieve the baseline to synchronise with the patient’s inspiratory and expiratory efforts, thereby improving comfort and reducing work of breathing.
Parameter | Set-range | Typical use |
---|---|---|
PA+ | 0 – 3 cmH2O above CPAP baseline | Inspiratory boost for weak inspiratory effort |
PA- | 0 – 3 cmH2O below CPAP baseline | Early expiratory unloading to facilitate exhalation |
Trigger flow | 3 – 20 L min-1 | Flow deviation required to activate PA |
Parameter | Set-range | Typical use |
---|---|---|
PA+ | 0 – 3 cmH2O above CPAP baseline | Inspiratory boost for weak inspiratory effort |
PA- | 0 – 3 cmH2O below CPAP baseline | Early expiratory unloading to facilitate exhalation |
Trigger flow | 3 – 20 L min-1 | Flow deviation required to activate PA |
The CPAP baseline (for example 5 cmH2O) is delivered continuously to keep the alveoli open. Pressure-assist pulses are additive or subtractive transients that ride on top of this baseline for 200 – 400 ms:
The baseline therefore remains constant over the respiratory cycle, while the PA waveform provides phasic synchronisation that can be titrated (0 – 3 cmH2O) without altering the underlying PEEP.
The trigger value (3 – 20 L min-1) represents the required deviation from the bias flow for the ventilator to recognise spontaneous effort:
Abbreviation | Full term | Clinical meaning | Equivalent |
---|---|---|---|
IPAP | Inspiratory Positive Airway Pressure | Peak pressure during inspiration in bi-level mode | PIP (Peak Inspiratory Pressure) |
EPAP | Expiratory Positive Airway Pressure | Baseline pressure during expiration | PEEP (Positive End-Expiratory Pressure) |
Sleep-medicine literature adopts IPAP/EPAP nomenclature, whereas critical-care texts often prefer PIP/PEEP; the underlying physiology is identical.
Variable | Common starting point | Usual clinical span |
---|---|---|
EPAP | 4 – 5 cm H2O | 4 – 10 cm H2O |
IPAP | 8 – 10 cm H2O | 8 – 25 cm H2O |
FiO2 | 0.30 – 0.50 | 0.21 – 1.00 (21 – 100 %) |
Clinical situation | EPAP (cm H2O) | IPAP (cm H2O) | Key objectives |
---|---|---|---|
Mild obstructive sleep-apnoea events in hospital | 4 – 6 | 8 – 12 | Maintain upper-airway patency; modest pressure-support for ventilation. |
Hypercapnic COPD exacerbation (pH 7.30 – 7.35) | 4 – 6 | 12 – 18 | Improve alveolar ventilation, targeting pH normalisation and PaCO2 decline. |
Acute hypoxemic pneumonia (non-hypercapnic) | 5 – 8 | 10 – 16 | Recruit atelectatic alveoli, enhance oxygenation, and lower work of breathing while avoiding excessive tidal volumes. |
Obesity hypoventilation or morbid obesity (> 35 kg m-2) | 6 – 10 | 16 – 22 | Counteract high pleural pressures; larger pressure-support to achieve adequate tidal volumes. |
Severe restrictive neuromuscular disease | 4 – 6 | 18 – 25 | Generate tidal volumes 8 – 10 mL kg-1 predicted body weight; prevent atelectasis. |
Close observation of mask fit, leaks, and patient–ventilator synchrony is essential.
Parameter | Lower setting | Higher setting | Clinical caveats |
---|---|---|---|
EPAP (Expiratory Positive Airway Pressure) |
|
|
Incremental increases of 1 – 2 cm H2O are preferred. Monitor blood pressure, oxygen saturation, and signs of auto-PEEP in obstructive lung disease. |
IPAP (Inspiratory Positive Airway Pressure) |
|
|
Increase IPAP in 2 cm H2O steps while observing tidal volume (target 5 – 8 mL kg-1) and PaCO2. Reassess for gastric distension, excessive leak, and patient tolerance. |
The OmniOx HFT700 offers S , T , and S/T modes; ResMed platforms additionally provide ST/SV (adaptive servo-ventilation) and related algorithms. Comparative characteristics are summarised below.
Mode | Cycling principle | Typical indications | Advantages | Limitations |
---|---|---|---|---|
S (Spontaneous) | Patient effort triggers & terminates each breath | Intact respiratory drive (e.g., OSA, mild COPD) | Natural timing, high comfort | No backup — apnoea risk if hypoventilation occurs |
T (Timed) | Ventilator delivers fixed RR & Ti regardless of effort | Absent drive (neuromuscular disease, CNS depression) | Guaranteed minimum ventilation | Potential asynchrony; comfort trade-off |
S/T | Spontaneous preferred; timed backup if no trigger within preset interval | Variable or intermittent drive (obesity hypoventilation, overlap OSA–COPD) | Safety net with good comfort balance | Requires leak management to avoid auto-triggers |
ST/SV * | As S/T, but servo algorithm varies pressure support breath-by-breath to target recent average ventilation | Central sleep apnoea, Cheyne-Stokes respiration, complex sleep apnoea | Dynamic stabilisation of PaCO 2 ; mitigates periodic breathing | Not available on HFT700; contraindicated in chronic hypercapnia without close monitoring |
* ResMed labels the servo variant as ASV or Adapt SV .
Spontaneous-only mode (S): In the spontaneous (S) mode on a bi-level device, every breath is initiated and terminated by the patient. The ventilator simply supports each inspiration with increased pressure (IPAP) and allows exhalation at the lower pressure (EPAP). There are no machine-triggered breaths at all. Consequently, in S mode, settings for a backup rate or a fixed Ti are absent because they are not needed—the patient’s respiratory centre is fully in control of timing. This mode is common for patients who have sufficient drive to breathe but need support (for example, many obstructive sleep apnoea patients on BiPAP or patients with obesity hypoventilation who are mostly breathing spontaneously).
Timed mode (T): In a timed mode, the device delivers breaths entirely according to preset timing, ignoring patient effort. For instance, if set to 12 breaths per minute with a Ti of 1.2 s, the ventilator will cycle to IPAP for 1.2 s and back to EPAP for the remainder of each 5-second cycle, regardless of what the patient does. T mode is essentially like an assist/control mode on a ventilator where every breath is machine-cycled. This mode would be used for patients who cannot breathe adequately on their own at all (for example, someone with a high spinal cord injury or severe neuromuscular disease in acute care, or during certain procedural sedations). In home bi-level units, pure T mode is less common, but some devices do allow it for specific clinical indications.
Spontaneous/Timed mode (S/T): The S/T mode is a blend of spontaneous and timed. As detailed earlier, it behaves like spontaneous mode as long as the patient is breathing above the backup rate, but it will initiate a breath if the patient becomes too slow or stops. This mode is very useful in chronic respiratory insufficiency conditions where the patient has a pattern of breathing on their own but is at risk of apnoea or hypoventilation. It provides peace of mind that the ventilator will “kick in” if needed. Most advanced bi-level machines intended for home ventilation (like for neuromuscular disease, obesity hypoventilation, etc.) offer S/T mode because it covers both needs in one setting.
Servo Variant (SV), Adaptive and Volume-assured modes: Beyond the basic S, T, and S/T, manufacturers have developed modes like volume-assured pressure support (where the machine adjusts pressure to meet a target tidal volume) and adaptive servo-ventilation (the SV/ASV mode discussed above). These modes still fundamentally operate either by supporting spontaneous breaths or adding timed breaths, but they have additional control algorithms (for volume or ventilation targets). They typically still require the clinician to set a backup rate (except in pure CPAP or other purely passive therapies) and they operate with some form of Ti control when providing mandatory breaths.
Choosing and using modes: If a device is running in pure S mode, the clinician will notice that settings for RR and Ti (and sometimes even rise time, depending on the device) might be hidden or disabled on the interface. This is because they are irrelevant unless the machine is going to trigger breaths. When switching into a mode that includes machine-triggered breaths (like S/T, T, or an adaptive mode with backup), the interface will require inputs for RR, Ti, and possibly other parameters because these become crucial. The selection of mode is guided by the patient’s condition: a patient who breathes reliably but needs pressure support for hypoventilation or obstruction might do well on S mode; a patient who sometimes hypoventilates or has central apnoeas might need S/T (or ASV if primarily central apnoea); a patient with almost no drive at all would require T mode or a full ventilator support mode. It is important to fine-tune the backup settings (RR, Ti, trigger sensitivity, etc.) in any mode that provides them, so that when the ventilator does step in, it does so in harmony with the patient’s needs rather than causing discomfort or asynchrony.
The trigger level denotes the patient effort required to initiate inspiration. Typical defaults are pressure –2 cmH 2 O (range –1 to –5) or flow 2 L min -1 (range 1 – 5).
In bi-level ventilation, Ti has two roles:
Although volume-controlled (VC) ventilation relies on a set Ti to shape flow delivery, bi-level devices use Ti to define how long pressure support is applied during any machine-initiated breath and to set guardrails around patient-initiated breath duration.
Determination: For adults, a starting Ti of about 1.2 s—the factory default on the HFT700—is typical; shorten it (< 0.8 s) when there is a risk of air-trapping (e.g., in COPD), or lengthen it (1.2 – 1.5 s) in restrictive lung disease to improve oxygenation. Values outside 0.5 – 2.0 s are seldom required in adult practice.
Rise time is the interval from EPAP to IPAP after a breath is triggered.
Even outside of volume-controlled modes, a mismatched rise time can provoke flow starvation (if too slow) or overshoot and discomfort (if too fast). Careful titration of rise time enhances patient-ventilator synchrony and comfort.
Initial adult bi-level template — individualise thereafter
- EPAP 5 cmH 2 O (increase to alleviate upper-airway obstruction or counter intrinsic PEEP).
- IPAP 10 cmH 2 O (pressure support of 5 cmH 2 O; titrate higher to achieve V T ≈ 6 – 8 mL kg -1 ).
- Backup RR 12 bpm (adjust if needed for chronic hypoventilation syndromes).
- Ti 1.0 s (alter per patient’s respiratory mechanics; see § III-4).
- Rise time ≈ 150 ms (tailor to patient comfort; see § III-5).
- Trigger sensitivity: flow trigger 2 L min -1 or pressure trigger –2 cmH 2 O; re-titrate after leak correction.
Continuous monitoring of leak, patient synchrony, delivered tidal volume, and blood gases is recommended after any setting change.
Often labeled as S/T on bi-level devices, this is a hybrid ventilation mode that combines patient-driven breathing with a timed safety net. In ST mode, the ventilator allows the patient to initiate breaths spontaneously (triggering from EPAP to IPAP whenever the device senses an inspiratory effort). If the patient does not initiate a breath within a preset time (determined by the backup rate setting), the ventilator automatically delivers a machine-initiated breath to maintain a minimum breathing frequency.
Mechanics: In ST mode, when a patient-triggered breath occurs, the device cycles to IPAP and back to EPAP based on the patient’s own inspiratory time or flow cycling criteria. If a patient effort is absent for longer than the interval set by the backup respiratory rate (for example, 5 seconds if the backup rate is 12 breaths per minute), the device will trigger a timed breath. That timed breath will be delivered at the set IPAP level and maintained for the duration of the set Ti (ensuring a full breath is given).
Indications: ST mode is indicated for patients with an inconsistent or intermittent respiratory drive. Examples include conditions like obesity hypoventilation syndrome, overlap syndrome (combined COPD and obstructive sleep apnoea), or certain neuromuscular disorders where patients breathe on their own most of the time but are at risk of episodic hypoventilation or apnoea. The mode provides a safety net by guaranteeing a minimal respiratory rate.
Advantages: ST mode offers the comfort and synchrony of spontaneous breathing with the assurance of backup ventilation. Patients breathe at their own rhythm when able, which feels natural, but if they slow down or pause, the machine ensures ventilation continues. This combination helps maintain adequate minute ventilation and prevents prolonged apnoeas without heavily compromising comfort.
Limitations: One challenge with ST mode is the potential for auto-triggering. If there is a significant leak in the mask or circuit, or if the device’s sensitivity is set too high, the ventilator might falsely detect a breath and trigger IPAP when the patient hasn’t actually made an effort. Such false triggers can disrupt sleep and lead to over-ventilation. Proper mask fit and appropriate trigger sensitivity settings are important to avoid this issue. Additionally, ST mode still relies on the patient initiating breaths most of the time, so it may not fully support someone who has almost no spontaneous drive (in those cases, a pure Timed mode might be necessary).
Servo ventilation, commonly known as Adaptive Servo-Ventilation (ASV), builds upon the S/T framework with an added layer of automation. In SV mode, the ventilator continuously monitors the patient’s recent ventilation (usually averaging the minute ventilation over a few minutes) and dynamically adjusts the level of pressure support on a breath-by-breath basis. The goal is to maintain a stable ventilation target; for example, the machine may target approximately 90% of the patient’s recent average ventilation. If the patient’s breathing decreases (as in a central apnoea or period of hypoventilation), the device increases support (raising IPAP) to deliver a larger breath. If the patient’s own breathing effort increases or they start hyperventilating, the device will reduce support to avoid over-ventilation.
Indications: SV modes are especially beneficial in conditions like central sleep apnoea, Cheyne-Stokes respiration (a pattern often seen in heart failure patients, with waxing and waning breaths and central apnoeas), and complex sleep apnoea (where treating obstructive events with CPAP/BiPAP reveals underlying central apnoeas). In these scenarios, the issue is not just airway collapse but a dysregulation of breathing rhythm or drive. ASV can adapt to these changes by providing just enough support to smooth out the ventilation.
Advantages: The primary advantage of servo ventilation is its ability to stabilise breathing automatically. By preventing excessive dips and rises in ventilation, it helps maintain a steadier PaCO 2 (carbon dioxide level) and more consistent oxygenation. Patients with periodic breathing patterns often experience improved sleep quality because the machine can effectively counteract central apnoeas and the arousals that accompany them. The therapy is highly responsive: each breath’s support level is tuned based on the immediate need, which can be very effective for certain forms of sleep-disordered breathing that do not respond well to fixed-level support.
Limitations: Not all ventilators offer SV/ASV modes (for instance, the OmniOx HFT700 does not include a servo-ventilation algorithm). Moreover, ASV must be used with caution in patients with certain conditions. For example, in patients with chronic hypercapnia (high CO 2 ) such as those with chronic COPD and CO 2 retention, aggressively maintaining ventilation could suppress their drive to breathe; such patients require careful monitoring and setting adjustments. Additionally, in some heart failure patients, early studies raised concerns about ASV potentially affecting mortality, so clinicians exercise caution and adhere to the latest guidelines when considering ASV for those individuals. Overall, SV is a sophisticated mode that should be titrated and monitored by experienced practitioners.
In summary, ST mode provides patient-initiated breathing with a timed backup to prevent apnoea, while SV mode extends this concept by adaptively adjusting pressure support to stabilise the patient’s ventilation in real time, targeting a consistent respiratory output even in the face of central breathing irregularities.
Backup rate (RR): This setting defines the minimum breaths per minute the ventilator will deliver in a mode that includes a backup (like S/T mode). If the patient’s own respiratory rate falls below this value, the ventilator will intervene by providing additional breaths. For example, a backup RR of 12 means the ventilator aims to deliver at least 12 breaths every minute. If the patient is breathing 15 times a minute spontaneously, the backup breaths won’t activate because the patient’s rate exceeds the backup. But if the patient pauses or slows down to, say, 8 breaths per minute, the device will start adding extra breaths to reach the rate of 12. It does so by monitoring the time between patient-initiated breaths and if a breath is missing, it triggers one.
Timed inspiratory time (Ti) for backup breaths: When the ventilator provides a mandatory breath (because the patient didn’t initiate one in time), it uses the set Ti to determine how long the inhalation lasts. Essentially, the machine-delivered breath in S/T mode is a pressure-controlled breath with a fixed inspiratory duration. For instance, with RR set to 12 (5-second cycle time) and Ti set to 1.0 s, if the patient fails to inhale after 5 seconds, the ventilator will give a breath that lasts 1.0 second at the IPAP level before cycling back to EPAP. This ensures that the delivered breath has an appropriate length to be effective (neither too brief to deliver volume nor too long to encroach excessively on exhalation time).
Behaviour in different modes: In pure spontaneous (S) mode, there is no backup rate; the ventilator will not trigger a breath on its own no matter how slow or irregular the patient’s breathing becomes. Likewise, there is no fixed Ti because the patient decides how long to inhale. In pure timed (T) mode, the ventilator uses the RR and Ti for every breath (completely controlling the respiratory cycle). In S/T mode, which is a blend, the device is usually in S mode (following the patient) but will switch to T mode temporarily whenever the patient falls below the set RR or has an apnoea. At that moment, the preset RR and Ti govern the breath timing. After that breath, if the patient resumes breathing above the backup rate, the ventilator goes back to pure support mode.
Clinical setting considerations: A common initial backup rate for adult patients on bi-level support is around 12 breaths per minute, which is close to a normal resting respiratory rate. This ensures that if the patient becomes apnoeic or markedly bradypnoeic (breathes too slowly), the ventilator will not let too much time pass without delivering a breath. However, this rate can be tailored: for someone with known chronic hypercapnia who might benefit from a lower rate and longer exhalation (to fully clear CO 2 each breath), the backup rate might be set a bit lower (e.g., 10). For someone who needs higher minute ventilation (e.g., obesity hypoventilation syndrome), a backup of 14–16 might be chosen to guarantee more breaths per minute. Similarly, the Ti for backup breaths is usually set around 1.0 s for an adult initially, but if the backup rate is high (meaning each breath cycle is shorter), Ti might need to be slightly shorter to allow enough time for exhalation. Conversely, if the backup rate is low or the patient’s comfortable breathing pattern includes longer inspirations, Ti could be set longer. The key is ensuring that the combination of RR and Ti leaves sufficient time for exhalation within each cycle (i.e., Ti must be shorter than the total cycle length, which is 60/RR). For example, at RR 12, the cycle length is 5 s; a Ti of 1.0 s leaves 4.0 s for exhalation, which is usually adequate. At RR 20 (cycle length 3 s), one would not set Ti to 3 s because that permits no exhalation; instead, Ti might be set around 1.0–1.5 s, leaving the remainder of each cycle for exhale.
Rise time controls how quickly the ventilator goes from the expiratory pressure (EPAP) to the inspiratory pressure (IPAP) at the start of each breath. Many devices allow the user to select qualitative rise settings (for example, “Fast,” “Medium,” or “Slow”) instead of specifying an exact time in milliseconds. The HFT700 provides adjustable rise time settings to optimise patient comfort and synchrony. The effects of these settings can be generalised as follows:
Rise time setting | Approximate rise time | Clinical effect |
---|---|---|
Fast | ≈ 50 – 100 ms | Very rapid pressurisation. This quickly delivers full support at the start of a breath. It is often beneficial for patients with obstructive lung disease (e.g., COPD) because it helps overcome intrinsic PEEP and any initial airway resistance, reducing the work to initiate a breath. However, if set too fast for a given patient, it can feel like a sudden blast of air and may cause discomfort or even overshoot the patient’s inspiratory flow demand momentarily. |
Medium | ≈ 100 – 200 ms | Moderate pressurisation. This is a balanced default that provides support promptly but with a slightly gentler slope than the fastest setting. Many adult patients find this comfortable and effective. It offers a good compromise: it doesn’t delay pressure delivery much, so it still assists in unloading inspiratory effort, but it’s less abrupt than the fastest rise, potentially improving tolerance. |
Slow | ≈ 200 – 300 ms | Gradual pressurisation. The pressure takes longer to ramp up to the full IPAP. This can be more comfortable for patients who are sensitive to rapid pressure changes, such as those with stiff lungs (restrictive disease) or paediatric patients. It can also help if a patient is prone to overshooting the pressure (where a fast rise might cause a pressure spike that the patient doesn’t need). The downside is that if the rise is too slow, a patient might feel they are not getting enough air at the beginning of the breath, leading to a sense of air hunger or “starved flow” until the pressure finally builds up. |
Proper rise time adjustment can significantly improve patient-ventilator synchrony. A general approach is to start with a medium setting and adjust based on patient feedback and observed waveforms. If the patient seems uncomfortable at the start of each breath or if inspiratory flow does not meet their demand (e.g., they are drawing in deeply, indicating they want more support faster), the rise time may be increased (faster). If the patient appears comfortable but is startled by or fights the initial rush of air, slowing the rise time might help. Importantly, rise time does not change the total amount of pressure support given—just the delivery profile. Therefore, it should be tuned to the patient’s comfort and the characteristics of their disease (fast for obstructive diseases needing quick help, slower for comfort in restrictive diseases), all while ensuring the patient’s own effort is effectively assisted.
With Auto Start enabled, the HFT700 remains in standby until its flow-sensor detects spontaneous breathing against the circuit (typically > 2 – 3 L min-1 differential). Once detected, the device automatically initiates the last-used therapy mode (HFOT, CPAP, or NIV) without pressing the start button.
BiPAP (Bilevel Positive Airway Pressure) and PS (Pressure Support) are closely related concepts in positive-pressure ventilation, but they refer to different things:
This alternating pressure support helps splint the airway open, improve tidal volume and reduce work of breathing without an endotracheal tube.
Aspect | BiPAP | PS (Pressure Support) |
---|---|---|
What it names | A device/therapy (often trademarked by Philips/Respironics) for non-invasive bilevel ventilation | A ventilator mode/parameter that can be applied invasively or non-invasively |
Pressure settings | Two absolute pressures listed (e.g. 15/5 cmH₂O) | One differential value (e.g. PS = 10 cmH₂O on top of a 5 cmH₂O PEEP) |
Triggering breaths | Can be spontaneous or timed, but primarily assists patient effort | Requires patient effort to trigger each supported breath |
Use cases | Outpatient sleep apnea, COPD exacerbations, cardiogenic pulmonary edema | Any ventilator—ICU or NIV—where you want to assist spontaneous breathing with a set pressure boost |
Alveolar pressure | “Stand-alone” pressures: IPAP = 15, EPAP = 5 ⇒ alveolar insp. 15, exp. 5 | “Additive” on a vent: PEEP = 5 + PS = 10 ⇒ alveolar insp. 15, exp. 5 |
In practice, a BiPAP machine implements pressure support ventilation in a non-invasive form, but PS itself is the mode/parameter that any ventilator (invasive or non-invasive) uses to augment spontaneous breaths.
Written on July 3, 2025
Amato, M. B. P. et al. (2015). Driving pressure and survival in the acute respiratory distress syndrome. The New England Journal of Medicine, 372(8), 747-755. https://doi.org/10.1056/NEJMsa1410639
ARDSnet. (2008, July). Mechanical Ventilation Protocol Summary. NIH NHLBI ARDS Clinical Network. View Protocol.
Cairo, J.M. (2023). Pilbeam's Mechanical Ventilation: Physiological and Clinical Applications (8th ed.). Elsevier.
Tobin, M. J. (Ed.). (2013). Principles and Practice of Mechanical Ventilation (3rd ed.). McGraw-Hill Education.
The Acute Respiratory Distress Syndrome Network. (2000). Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The New England Journal of Medicine, 342(18), 1301-1308. https://doi.org/10.1056/NEJM200005043421801
Check out the YouTube channel LOVmediteck for more information.